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resumo 
 
 
A proteína fosfatase-1 (PP1) é uma proteína fosfatase ubíqua e específica 
para a desfosforilação de resíduos de serina e treonina, que participa na 
regulação de diversos processos celulares. Em mamíferos, a actividade da 
PP1 está relacionada com a motilidade dos espermatozóides durante o 
percurso no tracto epididimal. Esta holoenzima é composta por uma 
subunidade catalítica, denominada PP1c, e por proteínas que interagem com a 
PP1 (PIPs) e a dirigem para a proximidade de substratos, determinando a sua 
actividade. A PP1 é codificada por três genes distintos: PP1α, PP1β e PP1γ. 
As isoformas PP1γ1 e PP1γ2 são originadas por splicing alternativo do gene 
PP1γ. PP1γ1 é uma isoforma ubíqua e a PP1γ2 é expressa maioritariamente 
no testículo e espermatozóides. O inhibidor-2 (I-2) de mamífero é uma PIP 
ancestral que se liga à PP1c, resultando na inibição da actividade da PP1. A 
reactivação deste complexo é desencadeada pela desfosforilação do I-2 no 
resíduo de Thr73 pela GSK-3.  
Atendendo às diversas funções que têm sido atribuídas à PP1, com base nas 
suas subunidades reguladoras, é crucial identificar novas PIPs. Assim, com o 
objectivo de identificar novas PIPs em testículo humano, procedeu-se ao 
rastreio de uma biblioteca de cDNA de testículo humano pelo método de dois 
híbrido de levedura, usando a PP1γ1 e PP1γ2 como isco. Foi assim obtido um 
clone muito semelhante ao I-2, denominado I-2L. Após um estudo comparativo 
por análise bioinformática, a principal diferença detectada foi a substituição de 
um resíduo de Thr73 por um de Pro73, no I-2L, conduzindo à ausência do local 
de fosforilação pela GSK-3, o que resulta num novo mecanismo de regulação 
para o complexo PP1γ2-I-2L. A presença de I-2/I-2L em espermatozóides 
humanos foi confirmada pelos métodos de Western blot e imunocitoquímica. 
As proteínas I-2/I-2L e a PP1γ2 co-localizam na peça intermédia e principal do 
flagelo dos espermatozóides, em concordância com o papel do complexo 
PP1γ2-(I-2/I-2L) na motilidade dos espermatozóides. A semelhança entre o I-2 
e I-2L, em termos da sequência de aminoácidos (95%), origina um novo 
desafio na diferenciação destas duas proteínas. Consequentemente, foi 
analisado o fingerprint proteolítico do I-2 e I-2L para posterior análise por 
espectrometria de massa, sendo esta uma abordagem eficaz para provar a 
existência do I-2L in vivo. Estudos estão presentemente a decorrer no sentido 
de validar, por espectrometria de massa, a sequência de aminoácidos do I-2L 
imunoprecipitado de espermatozóides humanos.  
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abstract 
 
Protein phosphatase-1 (PP1) is a ubiquitously expressed serine/threonine 
protein phosphatase that controls several cellular processes. In mammalian 
sperm, changes in PP1 activity correlates with sperm motility development 
during the transit through the epididymis. The PP1 holoenzyme structure is 
composed of a conserved subunit termed PP1c and PP1-interacting proteins 
(PIPs) which direct the holoenzyme to the proximity of its substrates, 
determining their activity. The catalytic subunit of PP1 is encoded by three 
different genes termed PP1α, PP1β and PP1γ. PP1γ1 and PP1γ2 are 
alternatively spliced isoforms of the PP1γ gene. PP1γ1 is ubiquitously 
expressed whereas PP1γ2 is mainly expressed is testis and sperm. 
Mammalian inhibitor-2 (I-2) is an ancient PIP that binds to PP1c, resulting in the 
inhibition of PP1 activity. The reactivation of this complex is triggered by 
phosphorylation of I-2 at Thr73 residue by GSK-3.  
Given all the roles that have been proposed to PP1 based on its binding 
subunits it seemed very important to identify novel PIPs. Thus, in order to 
search for novel PP1 regulator in human testis yeast two-hybrid screens were 
performed using PP1γ1 and PP1γ2 as baits to screen a human testis cDNA 
library. A clone was obtained very similar to I-2, termed I-2 Like (I-2L). After 
bioinformatics analysis comparison, the main difference detected was 
Thr73/Pro73 substitution which abolishes the GSK-3 phosphorylation site. This 
introduces a new regulatory mechanism for the PP1γ2-I-2L complex. The 
presence of I-2/I-2L in human sperm was confirmed by immunoblot and 
immunocytochemistry analysis. I-2/I-2L and PP1γ2 co-localize endogenously in 
the middle- and principal- piece of spermatozoa flagellum consistent with the 
role of PP1γ2-(I-2/I-2L) complex in sperm motility. The similarities between I-
2/I-2L in terms of amino acid sequences (95%) introduced a challenge to 
differentiate I-2 and I-2L proteins. Hence, the proteolytic fingerprint of I-2 and I-
2L was analyzed for further mass spectrometry (MS) analysis, and concluded 
that this was a fine approach to prove the existence of I-2L in vivo. Studies are 
now in progress in order to validate, via MS analysis, the amino acid sequence 
of I-2L immunoprecipitated from human sperm.  
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Abbreviations 
 
aa Amino acid 
AC Adenylyl cyclase 
Ade Adenine 
ADP Adenosine diphosphate 
APS Ammonium persulfate 
ATP Adenosine triphosphate 
AKAP4 A-kinase-anchoring protein 4 
Arg Arginine 
BCA Bicinchoninic acid 
BLAST Basic Local Alignment Search Tool 
BM Binding motif 
BSA Bovine serum albumin 
cAMP Cyclic AMP (Adenosine 3´, 5´-monophosphate) 
cDNA Complementary deoxyribonucleic acid 
Cdk Cyclin-dependent kinase 
Cdk 5 Cyclin-dependent kinase 5 
CKII Casein kinase II 
Da Dalton 
DARPP-32 Dopamine and cAMP-regulated phosphoprotein 32 kDa 
DNA Deoxyribonucleic acid 
ECL Enhanced chemiluminescence 
ELM Eukaryote Linear Motif resource 
FITC Fluorescein isothiocyanate 
GAL4 Gal4 transcription factor 
GAL4-AD Gal4 activation domain 
GAL4-BD Gal4 DNA binding domain 
GSK-3 Glycogen synthetase kinase 3 
His Histidine 
Hr Hour 
I-1 Inhibitor-1 
I-2 Inhibitor-2 
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I-2L Inhibitor-2 Like 
I-3 Inhibitor-3 
I-4 Inhibitor-4 
IP Immunoprecipitation 
IUPs Intrinsically unstructured proteins  
K Lysine 
LB Loading buffer 
Leu Leucine 
LGB Lower gel buffer 
Lys Lysine 
min  Minute  
mRNA Messenger ribonucleic acid  
MAPK Mitogen-activated protein kinase 
MYPT Myosin phosphatase targeting subunit 
MS Mass spectrometry 
NCB Non-capacitating buffer 
Nek2 NimA-related protein kinase 
OD Optical density 
PBS Phosphate buffered saline 
PI3 Phosphatidyl inositol kinase-3 
PIPs PP1-interacting proteins 
PKA Protein kinase A 
PKB Protein kinase B 
PKC Ca
2+
/phospholipid-activated protein kinase 
PP1 Protein phosphatase 1 
PP2A Protein phosphatase 2A 
PP1c Protein phosphatase 1 catalytic subunit 
PPM Metal ion dependent protein phosphatase 
PPP Phosphoprotein phosphatase 
Pro Proline 
PTP Tyrosine protein phosphatase 
R Arginine  
RNA Ribonucleic acid 
RT Room temperature 
SDS Sodium dodecyl sulphate 
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SDS-PAGE Sodium dodecyl sulphate – polyacrylamide gel electrophoresis 
Sec  Seconds  
Ser Serine 
TBS Tris-buffered saline solution 
TBST TBS supplemented with Tween detergent 
TEMED N, N, N´, N' - Tetramethylethylenediamine 
Thr Threonine 
Trp Tryptophan 
Tyr Tyrosine 
UAS Upstream activating sequence 
UGB Upper gel buffer 
WR Working reagent 
X-α-gal 5-bromo-4-chloro-3-indolyl-alpha-D-galactopyranoside 
YTH Yeast two-hybrid 
  
  
 
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 11 
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1.1.  Protein phosphorylation 
 
The reversible phosphorylation of proteins is a major intracellular control 
mechanism involved in a wide range of eukaryotic cellular responses. The control of 
biological events requires strict regulation using complex protein phosphorylation and 
dephosphorylation strategies. Phosphorylation is mediated by the coordinated action of 
protein kinases and phosphatases (Hurley et al., 2007). The reversible protein 
phosphorylation involves either the addition of a phosphate group via the transference of 
the terminal phosphate from ATP to an amino acid residue by protein kinases or its 
removal by protein phosphatases (Figure 1).  
 
 
Figure 1: Schematic representation of reversible protein phosphorylation. Protein kinase moves a phosphate 
group from ATP to a target protein (protein phosphorylation) while a protein phosphatase catalyzes the 
removal of the phosphate group from the target protein (protein dephosphorylation). 
 
The importance of phosphorylation networks in eukaryotes is underscored by the 
estimated one-third of cellular proteins that are phosphorylated, with the vast majority of 
the modifications occurring on tyrosine, serine and threonine residues (Virshup and 
Shenolikar, 2009). The protein phosphorylation (or dephosphorylation) on these amino 
acid residues causes conformational changes in proteins, modifying their biological 
properties (Bollen, 2001; Ceulemans and Bollen, 2004).  
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Eukaryotic cells express various protein kinases and phosphatases, which have 
specific substrates, cellular localizations and regulation mechanisms. Whereas the number 
of tyrosine phosphatases is approximately the same of tyrosine kinases, the number of 
serine/threonine kinases is higher to that of serine/threonine phosphatases (Bollen, 2001; 
Ceulemans and Bollen, 2004). It is known that more than 400 human genes encode protein 
serine/threonine kinases but there are only about 40 genes that encode protein 
serine/threonine phosphatases. It seems that the protein kinases had mainly diversified by 
gene duplication and subsequent specification, whereas proteins serine/threonine 
phosphatases have diversified much more by increasing the variety of their regulatory 
subunits (Hendrickx et al., 2009).  
 
1.2.  Protein phosphatases 
 
Protein phosphatases belong to three unrelated gene families: the PPM family 
(metal ion dependent protein phosphatases), the PTP family (tyrosine protein 
phosphatases) and the PPP family (phosphoprotein phosphatases). The PPP family 
members comprise the serine/threonine phosphatases PP1, PP2A, PP2B, PP4, PP5, PP6 
and PP7 (Honkamen and Golden, 2002; Virshup and Shenolikar, 2009).  
A key defining feature of most PPP family members is that they are multimeric 
enzymes. No more than 13 human genes encode PPP catalytic subunits, which are 
associated with numerous PPP regulatory subunits that do not share extensive sequence 
conservation. Instead, they are identified by their physical association and function that 
provide the critical determinants for subcellular localization, substrate specificity, and fine-
tuning of phosphatase activity. Hence, these regulatory proteins confer remarkable 
complexity to protein phosphatases. Added to these regulatory subunits, an increasing 
number of PPP inhibitory proteins also control cell dephosphorylation capacity (Virshup 
and Shenolikar, 2009).  
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1.2.1.  Recognition of substrates by protein phosphatases 
 
Serine/threonine-specific protein phosphatases (PPs) can be classified into different 
types on the bases of their substrate specificity and responses to a defined set of inhibitors 
and activators (Ingebritsen and Cohen, 1983). These criteria define four types of catalytic 
protein phosphatases: PP1, PP2A, PP2B and PP2C. PP1 can be distinguished from the 
other types by its sensitivity to two heat-stable inhibitors, I-1 and I-2 (Vijayaraghavan et 
al., 1996), and type 2 PPs can be sub-classified into PP2A, PP2B, and PP2C based on 
cation requirements. PP1 and PP2A do not require divalent cations for activity whereas 
PP2B and PP2C require Ca
2+
/calmodulin and Mg
2+
, respectively, for activity (Smith et al., 
1996). Furthermore, techniques such as yeast two-hybrid (YTH) assays and co-
immunoprecipitation (Co-IP) suggested that a physical association with phosphatases may 
be a hallmark of all substrates, and that the binding of phosphatases to substrates narrows 
their substrate specificity, limiting them to dephosphorylate a subset of the phosphorylated 
amino acids in the target peptide sequence that interacts with both the regulatory and 
catalytic subunits (Virshup and Shenolikar, 2009).  
 
1.2.2.  Protein Phosphatase 1 (PP1) 
 
Protein phosphatase-1 (PP1) is a ubiquitous and conserved enzyme that is estimated 
to catalyze a third of all protein dephosphorylations in eukaryotic cells (Hendrickx et al., 
2009). This major serine/threonine protein phosphatase controls several cellular processes 
such as glycogen metabolism, muscle contraction, cell cycle, gene expression, and 
neuronal activity (reviewed in Virshup and Shenolikar, 2009). In mammalian sperm, a 
change in PP1 activity correlates with sperm motility development during the transit 
through the epididymis, consistent with a major role for PP1 in the control of this process 
(Vijayaraghavan et al., 1996). PP1 interacts with dozens of regulatory proteins, and its 
function is associated with regulatory components that direct the enzyme to various sub-
cellular compartments in the proximity of substrates and modulate the phosphatase activity 
(Fardilha et al., 2010). 
 
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 15 
 
 
1.2.2.1. PP1 catalytic and regulatory subunits 
 
PP1 holoenzymes are composed of a highly conserved catalytic subunit termed 
Protein Phosphatase 1 catalytic subunit (PP1c) and one or two regulatory (R) subunits 
(Bollen, 2001). Although the activity of PP1c can be regulated by cell cycle dependent 
dephosphorylation of serine/threonine residues in its C-terminus, the regulation of PP1 
holoenzymes by extracellular signals is mainly mediate by the R subunits (Bollen, 2001). 
The catalytic subunit of PP1 can be encoded by three different genes, termed PP1, 
PP1/, and PP1 (Hurley et al., 2007; Smith et al., 1996). Figure 2 shows an amino acid 
sequence alignment of the different PP1c isoforms. Two isoforms of PP1, PP11 and 
PP12, are alternatively spliced isoforms generated from a single gene. This two variants 
are identical in all respects, except that PP12 has a unique 21 amino acid carboxyl 
terminus extension (da Cruz e Silva et al., 1995; Zhang et al., 1993). PP11 is ubiquitously 
expressed, whereas PP12 is expressed mainly in the testis and spermatozoa (Huang and 
Vijayaraghavan, 2004; Smith et al., 1996; Vijayaraghavan et al., 1996).  
 
Figure 2: Analysis of homology of PP1 isoforms using a CLUSTALW multiple sequence alignment. 
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Mammalian PP1 isoforms do not exist freely in the cell but tightly associate with 
different interactors (Figure 3) that determine when and where the phosphatase acts 
(Hurley et al., 2007). Based on the effect on PP1c, the best-characterized R subunits can be 
generally divided into three groups; a group represented by activity-modulating proteins, 
including the inhibitor-1, inhibitor-2 and inhibitor-4 that, depending on their 
phosphorylated state, block the activity of PP1c (Figure 3 and 4), a group of R subunits 
contains the targeting proteins which binds both PP1c and one of the substrates, for 
example, MYPT1 binds PP1c as well as specific substrates such as myosin, and finally, a 
group of proteins that directly and tightly associates with PP1c, defining a subset of its 
substrates that can function as activity modulators (Bollen, 2001; Hendrickx et al., 2009).  
 
 
Figure 3: Regulation of protein phosphatase 1. AProtein phosphatase 1 is controlled by regulatory 
interactions (green) and inhibitors (orange). BRegulatory interactions control the entrance of the substrate in 
to the catalytic site. PP1 is represented without and with MYPT1 subunit. The catalytic metals in the active 
site are shown in yellow, PP1 is represented with electrostatic potential, and MYPT1 in green. The 
interaction of MYPT1 with PP1 stabilizes its flexible C-terminus that extends from the PP1 catalytic subunit. 
CA PP1 inhibitor physically blocks the active site. PP11 without or with inhibitor-2 (I-2) (orange) is 
depicted with the catalytic subunits (adapted from Virshup and Shenolikar, 2009).  
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It has been demonstrated that the binding of R subunits to PP1c is mediated by 
multiple, degenerated, short sequence motifs and that the R subunits can share interaction 
sites in a combinatorial control of PP1c (Figure 4) (Bollen, 2001).  
 
 
Figure 4: A Schematic structure of protein phosphatase 1 (PP1) holoenzymes. PP1c has multiple points of 
interaction with a regulatory subunit (R), which direct the holoenzyme in proximity to its substrates, 
determining its activity. Hormones and metabolites modulate the substrate actions, controlling PP1 
holoenzyme. BCombinatorial-control model of PP1c is represented with different binding sites for R 
subunits. The R subunits are activity modulators (R1), targeting proteins (R2) and substrates (R3). These R 
subunits have multiple contacts with PP1c binding sites, contributing for the specificity with the binding 
products on PP1c (adapted from Bollen, 2001).  
 
The regulatory proteins are structurally unrelated, but most of them share a short, 
degenerate RVXF-type docking motif that binds to a hydrophobic surface groove located 
on a surface behind the PP1c active site (Hendrickx et al., 2009; Virshup and Shenolikar, 
2009), which has a consensus (R/K) XA (0-1) (V/I)XB (F/W) sequence, where XA is any 
amino acid, present or absent, and XB is any amino acid, except proline. The binding of the 
RVXF sequence to PP1c does not cause important conformational changes of the catalytic 
subunit but increases the local concentration of the interactor (Hendrickx et al., 2009).  
Studies on MYPT1 and I-2 (Figure 5) indicated that the RVXF motif can function 
as an anchor for PP1c and enables these R subunits to make additional contacts with the 
PP1 in a cooperative manner.  
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Figure 5: Representation of Inhibitor-2 and MYPT1 sites that mediate the interaction of the regulatory 
subunits (blue bars) with the catalytic subunits of PP1c. The RVXF motifs are shown in red and extra 
phosphatase-interaction sites are represented in beige (adapted from Bollen, 2001).  
 
Moreover, the RVXF-binding pocket is surrounded by acidic residues that might 
provide additional binding sites for the basic residues often found N-terminally to the 
RVXF motif. Other surface areas of PP1c that interact with R subunits are the catalytic site 
and the β12-β13 loop. In addition, the site that lies adjacent to the RVXF binding groove 
(Figure 6) has been identified as a binding pocket for the N-terminal K[GS]ILK motif of I-
2 (Bollen, 2001; Wakula, 2003). 
 
Figure 6: Structure of PP1γ (ribbons) bound to an RVXF-containing peptide. A Frontal sight of PP1 with 
three grooves originated from the catalytic site. The β12/β13 loop is drawn at magenta and the α4/α5 /α6 
triangle in yellow. The acidic residues from the acidic groove are shown in purple. B Dorsal view of PP1 
with its catalytic site. The RVXF-containing peptide is represented in green. The cooperative RVXF-binding 
channel is lined by residues of the β-strand, β14 and the neighboring residues (blue). The protein surface near 
the channel, which bind the basic residues prior to the V-position of the RVXF-motif, is negative charged due 
to the acidic residues (red and orange). Some of these residues (red) are also related with K[GS]ILK-motif of 
I-2 (adapted from Ceulemans and Bollen, 2004). 
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Recent analysis of RVXF-based PP1 interactome provided new insights into the 
conserved features of the RVXF motif and led to the discovery of additional common PP1 
binding elements, described as the SILK-motif:[GS]-IL-[RK] and MyPhoNE-motif 
(reviewed in Hendrickx et al., 2009). One of the PP1docking motifs of I-2 matches to that 
consensus sequence [GS]-IL-[RK] indicating that the SILK-motif is essential for the potent 
PP1 inhibition by I-2 (Hurley et al., 2007). Hendrickx et al. (2009) found that the SILK-
motif also occurs in six other PP1 interactors and is always N-terminal to the RVXF-motif 
and that the importance of this motif for the anchoring of PP1 is interactor dependent.  
 
1.2.3. Protein Phosphatase 1 Inhibitors 
 
1.2.3.1. Heat-stable Protein Phosphates 1 Inhibitors  
 
PP1 binds to a number of small cytosolic inhibitory proteins (Li et al., 2007), 
including inhibitor-1 (I-1) and its isoform dopamine and cAMP- regulated phosphoprotein 
32 kDa (DARPP-32), inhibitor-2 (I-2), the mammalian smooth muscle specific PP1 
inhibitor CPI17, human HCG V gene product (inhibitor-3), the testis-specific PP1 inhibitor 
from Drosophila melanogaster that has 41% sequence similarity to mammalian I-2 
(inhibitor-t), and Glc8p that is a homologue of I-2 from Saccharomyces cerevisiae (Helps 
and Cohen, 1999). Effectively, the family of I-2 proteins exhibits considerable sequence 
variation, with I-2 from non-vertebrate species having only 30% identity with I-2 from 
vertebrates (Li et al., 2007). Despite these divergences in sequence, all these I-2 proteins 
have the same size (187-229 residues) and are heat stable, possibly due to the presence of 
charged and hydrophilic amino acid residues.  
I-2 family members have multiple phosphorylation sites for different kinases, such 
as Casein kinase II (CKII) (Li et al., 2007), the neuronal Cdc2-like protein kinase (NCLK), 
a heterodimer of Cdk5 and the regulatory p25 (Agarwal-Mawal and Paudel, 2001), the 
extracellular signal-regulated kinases (ERKs), the cyclin-dependent kinases (CDKs) 
(Hurley et al., 2007), and Glycogen synthase kinase-3 (GSK-3), which is highly specific 
for Drosophila melanogaster I-2 and Homo sapiens I-2 (Li et al., 2007). I-2 is also related 
to the regulation of other kinases that are complexed with PP1 during the cell cycle, 
activating the NimA-related kinase, Nek-2, to induce centrosome separation (Eto et al., 
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2002). Also, I-2 stimulates the Aurora-A kinase that is necessary for the centrosome 
maturation, assembly of the bipolar spindle, and proper chromosome segregation during 
cell division (Satinover et al., 2004).  
PP1 is sensitive to endogenous I-1 and I-2 whereas PP2 is insensitive. 
Comparatively, the inactivation of PP1 by I-1 is dependent on I-1 phosphorylation of a 
single threonine residue by cAMP-dependent protein kinase A (PKA), and by 
Ca
2+
/calmodulin-dependent dephosphorylation by PP2B, while I-2 does not necessarily 
require phosphorylation for PP1 inhibition (Smith et al., 1999; Vijayaraghavan et al., 
1996). The inhibition of PP1 by I-2 occurs through the binding to the catalytic subunit of 
PP1 to form an inactive cytoplasm form of the enzyme (PP1-I-2) that can be converted to 
active PP1 by phosphorylation of the bound I-2 by GSK-3 and other kinases (Smith et al., 
1996; 1999; Vijayaraghavan et al., 1996).  
 
1.2.3.2. GSK-3 protein kinase phosphorylates I-2 
 
GSK-3 is a ubiquitously expressed magnesium-adenosine triphosphate (Mg-ATP)-
dependent enzyme, with the two isoforms GSK-3α and GSK-3β being expressed in 
somatic cells (King et al., 2006). GSK-3 activity can be regulated by tyrosine and 
serine/threonine phosphorylation. Tyrosine phosphorylation increases GSK-3 catalytic 
activity. Serine/threonine phosphorylation is mediated by phosphatidyl inositol kinase-3 
(PI3-kinase) and protein kinase B (PKB) (King et al., 2006). The PI3-kinase, activated by 
cell adhesion, growth factors, and insulin, in turn activates PKB, which results in 
phosphorylation and inactivation of GSK-3 (Vijayaraghavan et al., 1996; 2000). Thus, 
GSK-3 has important functions in cellular signal transduction, like the activation of PP1 
accomplished through phosphorylation of I-2 on a threonine residue, resulting in the 
reactivation of the PP1-I-2 complex (Vijayaraghavan et al., 2000).  
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1.2.3.3. Protein phosphatase 1 Inhibitor-2  
 
Inhibitor-2 (I-2) is the most ancient PP1 regulatory protein, conserved from yeast to 
human (Li et al., 2007). Mammalian I-2 forms a stable and high affinity complex with 
PP1c termed ATP-Mg
2+
-dependent phosphatase complex. I-2 promotes a slower 
inactivation of PP1c to create a latent complex. The reactivation of this PP1c-I-2 complex 
is triggered by phosphorylation of the rabbit I-2 isoform at Thr72 residue by several 
protein kinases (described before), including the GSK-3 kinase (Hurley et al., 2007).  
 
1.2.3.4. Structure of PP1-Inhibitor-2 Complex 
 
The molecular basis by which I-2 modulates PP1 function is crucial for establishing 
the physiological role of PP1-I-2 complex and assessing the involvement of cell dynamic 
control of this protein phosphatase complex. The analysis of PP1-I-2 complex structure 
(Figure 7) highlights common structural determinants that mediate the inactivation of PP1c 
by I-2 and the inhibition of other serine/threonine phosphatases (Hurley et al., 2007).  
 
Figure 7: Crystal representation of the PP1c-I-2 complex. Ribbon structure of PP1c is depicted in blue, and 
that of I-2 is in magenta. Residue numbers indicate the start and the end positions for the observed regions of 
I-2, in addition to the last residue observed for PP1c (300). The location of the remaining catalytic 
manganese ion is indicated (Mn), plus the position of the water molecule (Wat) (adapted from Hurley et al., 
2007). 
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Studies on cocrystallization of PP1 with I-2 (Figure 7) shows that I-2 physically 
occludes the catalytic site displacing two catalytic metal ions to generate an inactive or 
latent enzyme. This inhibition can also be regulated. The phosphorylation of I-2 by GSK-3, 
and other kinases, restores PP1 activity, interestingly, without releasing I-2 from PP1 
(Virshup and Shenolikar, 2009). The close analysis on the PP1c-I-2 complex demonstrate 
that I-2, which lacked significant ordered structure, interacts with PP1c (Figure 8) to 
induce conformations that specifically enhances the formation of the PP1c-I-2 complex, 
not to modify the overall structure of PP1c, but to direct the association with the catalytic 
center and its ability to displace critical catalytic metals, providing the slower inactivation 
of PP1c (Hurley et al., 2007). 
 
Figure 8: Interactions of I-2 residues 12-17 and 44-56 with PP1c. ASurface representation of PP1c 
demonstrates the interaction between the I-2 residues 12-17 and the surface of PP1c. BRegion of PP1c to 
which residues 44-46 from I-2 bound. The characteristic surface PP1c  is represented in grey and the 
structure of I-2 is represented using atom-type colouring (adapted from Hurley et al., 2007). 
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1.2.3.5. Inhibitor-2 in human sperm 
 
Mammalian spermatozoa acquire their capacity for motility and fertilization during 
epididymal transit while concomitantly undergoes marked changes in chemical and 
physical properties. These changes are in shape, metabolic patterns, enzymatic activities, 
chemical and physical properties of the plasma membrane, ability to bind specific 
epididymal proteins, and in the female tract, aptitude to bind to the zona pellucida (Huang 
and Vijayaraghavan, 2004).  
Sperm motility and fertilization involves changes in protein phosphorylation, which 
is a balance between the action of protein kinases and phosphatases (Vijayaraghavan et al., 
2000). Sperm motility in immature spermatozoa can be initiated by treatments that 
stimulate protein kinase activity or inhibit protein phosphatase activity, suggesting that the 
potential for motility already exists in immature epididymal spermatozoa (Huang and 
Vijayaraghavan, 1996; 2004). During the passage through the epididymis, changes are 
observed in the intrasperm levels of cAMP, pH, and the calcium, mediators known to 
regulate the kinetic activity of mammalian sperm, and that presumably act through protein 
phosphorylation (Huang and Vijayaraghavan, 2004). Remarkably, these development 
changes that sperm undergo in the male epididymis occur in the absence of transcriptional 
or translational activity, and involve reversible phosphorylation of key proteins regulating 
sperm kinetic activity and metabolism (Vijayaraghavan et al., 1996).  
Sperm protein phosphorylation is directly related to motility, and it is increased by 
agents that elevate sperm cAMP levels. A key enzyme regulating sperm motility 
development is PP12, which is one isoform of PP1. High catalytic activity of sperm 
PP12 holds the motility in check in immature caput epididymal spermatozoa. Protein 
phosphatase inhibitors initiate motility in caput epididymal spermatozoa and stimulate 
motility in caudal epididymal spermatozoa (Huang and Vijayaraghavan, 2004). Given that 
PP12 is testis-enriched and the major isoform of PP1 in spermatozoa (Fardilha et al., 
2004; Vijayaraghavan et al., 1996; 2000), it is acknowledged that PP12 is essential for 
spermatogenesis and it is also a key enzyme in the development and regulation of sperm 
motility (Fardilha et al., 2004; Huang and Vijayaraghavan, 2004; Wu et al., 2007).  
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Sperm PP1 catalytic activity is regulated by its interaction with I-2 that resembles 
the one found in somatic cells (Vijayaraghavan et al., 2000). Of the known PP1 inhibitors, 
only an I-2-like activity is detected in mammalian sperm. Both human and monkey sperm 
contain the so named I-2-like activity as well as Mg-ATP-dependent GSK-3 activity 
(Smith et al., 1999). Once more, the inactive PP12-I-2 complex is activated by 
phosphorylation of this I-2-like activity by GSK-3 (Vijayaraghavan et al., 2000). In Figure 
9 is represented the role of PP12-I-2 complex in sperm motility. In caput human sperm, 
high GSK-3 activity levels induce phosphorylation of I-2 at the Thr73 residue, which in 
turn, enhances the PP1γ2 activity responsible for the lack of motility.  Along the 
epididymis, the decrease of GSK-3 activity enhances the formation of the PP12-I-2 
complex that promotes the initiation of sperm motility in the epididymis by the inactivation 
of PP12.  
 
Figure 9: Schematic illustration of the PP12-I-2 complex and its role in sperm motility. The binding of I-2 
to PP12 leads to the initiation of sperm motility in immature spermatozoa during epididymal transit. 
Serine/threonine phosphorylation decreases GSK-3 activity, enhancing the association of the PP12-I-2 
complex, which in turn results in the activation of sperm motility.  
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1.2.4.  Yeast two-hybrid (YTH) system  
 
Macromolecular interactions such protein-protein interactions are fundamental for 
all biological processes, including the regulation of signalling pathways (Lalonde et al., 
2008). The yeast two-hybrid (YTH) method is effective for the detection of these 
interactions (Koegl and Uetz, 2008). The two-hybrid system is able to detect the 
interaction between two proteins via transcriptional activation of one or several reporter 
genes and is also used for searching for new partners (the prey) of a given protein (the bait) 
(Figure 10).  
 
Figure 10: General overview of the yeast two-hybrid system. The bait (PP1) is fused to the DNA binding 
domain and the target protein (sequence from a testis cDNA library) is fused to the activation domain. If the 
bait and prey interact, the GAL4 binding domain (BD) and the GAL4 activation domain (AD) are brought 
together forming a functional transcriptional activator which leads to the transcriptional activation of a 
downstream reporter gene (adapted from Berggard et al., 2007).  
 
This method is based on the properties of the yeast GAL4 protein, which has two 
separable domains, one responsible for DNA binding and other for transcriptional 
activation. YTH assay is performed by expressing the two fusion proteins in yeast. The 
first contain the GAL4 DNA binding domain (BD) fused in-frame to bait protein and the 
other contains the GAL4 activation domain (AD) fused in frame to a target protein (the 
prey). The prey and bait constructs are introduced, by co-transformation or mating, into 
yeast strains containing the appropriate "Upstream Activating Sequence" (UAS) proximal 
to a reporter gene. When the bait and the target protein interact, the BD and the AD are 
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brought together forming a functional transcriptional activator which leads to the 
transcriptional activation of the reporter gene. Each GAL4 responsive gene contains a UAS 
target site, when GAL4 binds the UAS transcription is activated from a downstream 
promoter. By linking the GAL4 UAS with other metabolic genes (e.g. ADE2, HIS3, MEL1 
and lacZ) and by eliminating the wild type GAL gene, researchers have developed yeast 
strains that change phenotype when GAL4 is activated. Although the GAL4 DNA-BD can 
bind the UAS, it cannot activate transcription by itself. Transcription is activated only 
when the other half of the protein, GAL4 AD, joins the DNA-BD at the UAS. When using 
a large scale screen, a plasmid library, expressing cDNA-encoded AD-fusion proteins, can 
be screened by introduction into a yeast strain. These larger scale two-hybrid approaches 
typically rely on interaction by yeast mating (Parrish et al, 2006).  
The advantages of this method are the simplicity, the minor optimization 
requirement, and its ability to detect proteins interactions in vivo (Parrish et al., 2006). 
However this method may generate false positives. Even though two proteins can interact, 
it is not certain that they will interact in physiological conditions. Therefore, the biological 
relevance of the proteins identified must be confirmed using alternative methodology such 
as Co-IP and overlay (Koegl and Uetz, 2008). 
 
In order to identify proteins from a human testis cDNA library capable of 
interacting with the alternative spliced isoforms of PP1, PP11 or PP2, two separate 
YTH screens were performed, YTH1 and YTH2, respectively. These isoforms are identical 
except for the C-terminus (Figure 2). PP11 and PP12 were used as baits and this 
methodology was used to screen a testis cDNA library (Figure 10). The binding domain 
plasmid carries the yeast TRP1 gene and the PP11, or PP12, sequence (the bait) fused to 
the GAL4 BD. The activation domain plasmid carries the yeast LEU2 gene and a sequence 
from the cDNA library (the prey) fused to the GAL4 AD. The reporter genes used were 
MEL-1 which encodes α-Galactosidase and HIS3 and ADE4. The plasmids are 
transformed in yeast strain which requires tryptophan (trp), leucine (leu), histidine (his) 
and adenine (ade). If the two proteins (the bait and the prey) interact, the reporter genes 
will be activated and the yeast will grow on synthetic complex medium lacking the amino 
acids trp, leu, his and ade. The α-Galactosidase activity is detected by the formation of blue 
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yeast colonies on medium with the cromogenic substrate X--Gal (5-bromo-4-chloro-3-
indolyl alpha-D-galactopyranoside). 
 
From the testis cDNA library, using PP11 as bait (YTH1), were collected and 
identified 120 true positive clones. One of these clones, named 48T, was identified as a 
novel PP11 binding protein (NM_206858), termed I-2L.  
 
1.3. Aims of this thesis 
 
PP1 multiple functions rely on its binding partners, PP1 interacting proteins (PIPs) 
that specify its location, preferable substrates and its activity status. The identification of 
novel PIPs is a mean of attributing new functions to PP1 catalytic subunit. We have 
undertaken an in-depth survey using the YTH approach to identify proteins, expressed in 
human testis, capable of interacting specifically with the alternatively splicing isoforms of 
PP1γ. Among several physiologically interesting proteins, I-2L was identified as a novel 
putative PP1 binding protein.  
Previous studies have attributed an important role to PP1γ2 in mammalian sperm 
motility. Thus, understanding the molecular basis by which I-2L could be modulating 
PP1γ2 function in sperm is critical for establishing a physiological role to the PP1γ2-I-2L 
complex. Furthermore, the contribution of the holoenzyme PP1-I-2L to male (in)fertility 
will be assessed. The objectives of this study were: 
 
- To analyze the I-2L nucleotide and amino acid sequences using bioinformatics 
tools.  
- To determine the expression of endogenous I-2/I-2L in human sperm and testis.  
- To determine the subcellular localization of PP1γ2-(I-2/I-2L) complex in human 
spermatozoa. 
- To optimize the immunoprecipitation assay of I-2/I-2L using a specific anti-I-2 
antibody. 
- To validate the expression of I-2L in vivo by immunoprecipitation from human 
sperm followed by mass spectrometry analysis.  
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2. Bioinformatics analysis of I-2L 
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2.1.  Identification of Inhibitor-2 Like and comparison with Inhibitor-2 
 
There are three different isotypes of protein phosphatase inhibitor-2 (I-2), I-2α1, I-
2α2 and I-2β. Two genes encode these three isotypes, with I-2α1 and I-2α2 being isoforms 
from a single gene, originated from alternative splicing. I-2α2 and I-2β are expressed 
exclusively in testis, and all three isotypes of I-2 are expressed during sperm maturation 
(Osawa et al., 1996). Here we report the identification of a new protein, termed Inhibitor-2 
Like I-2L, from a unique clone (named 48T) (in red, Figure 11) obtained in a YTH screen 
using PP1γ1 as bait, starting at nucleotide 57 and ending at nucleotide 901 of the sequence 
NM_206858 in the GenBank database ID (Table 1). 
 
Table 1: Inhibitor-2 like (I-2L) clone isolated from the yeast-two hybrid (YTH) screen. 
Clone ID YTH1 PP1 BM chr Database ID Insert (bp) Nº clones 
PPP1R2-L 
I-2L 
48T KLHY 5 NM_206858 ≈400 1 
 
Clone 48T (interaction with PP1γ1) was selected for the further study. The occurrence of a consensus PP1 
binding motif (PP1 BM) is indicated by the corresponding sequence.  
 
Using the Blast2 algorithm, we aligned the NM_206858 sequence with the human 
genome and concluded that this sequence is encoded by a gene that is single-exon and 
maps to chromosome 5, whereas I-2 gene is a five exon gene on chromosome 3. As an 
intronless gene, I-2L may be evolved into a pseudogene nevertheless it seems to have 
coding capacity since it came from a cDNA expression library.  
By definition, a pseudogene is a gene copy that does not produce a functional, full-
length protein. In fact, the human genome is estimated to contain up to 20,000 
pseudogenes (Hirotsune et al., 2003). In spite of pseudogenes have been defined as 
nonfunctional sequences of genomic DNA or “junk” DNA (Balakirev and Ayala, 2003), 
originally derived from functional genes, it is therefore assumed that pseudogenes are not 
subjected to natural selection and consequently, pseudogene mutations are selectively 
neutral, being often evolutionary conserved and transcriptionally active. Moreover, 
pseudogenes may be considered as potogenes, i. e. DNA sequences which have potentiality 
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to become new genes or acquire new functions (Balakirev and Ayala, 2004). An expressed 
pseudogene may regulate the mRNA stability of its homologous coding gene (Hirotsune et 
al., 2003). In literature, there are some examples of expressed pseudogenes. For instance, 
Sun et al. (2008) found that CRIPTO3, a presumed pseudogene, has an open reading frame 
that differs from Cripto-1 in six amino acids. CRIPTO3 mRNA is the CRIPTO message 
expressed in many cancer samples, indicating that CRIPTO3 is actually an expressed gene. 
 
Figure 11: Nucleotide and amino acid sequences of inhibitor-2 Like (I-2L) (NM_206858). In red is the 
sequence of the clone 48 (it starts at nt 57 and ends at nt 901). Underlined are the important amino acid 
sequences involved in PP1 binding. The blue adenine is absent in clone 48T.  
 
Using the ClustalW algorithm we aligned the I-2 and I-2L amino acid sequences, 
and found that I-2L is 97% identical at the nucleotide level and 95% identical at the amino 
acid level to I-2. In Figure 12 are highlighted the similarities and differences between this 
two proteins, being the most preeminent difference the substitution of Thr for Pro at the 
position 73. This replacement constitutes a very interesting aspect, because of the 
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importance of this phosphorylation site for the regulation of PP1-I-2 complex. Thr73 can 
be phosphorylated by several protein kinases such as GSK-3, the cyclin dependent kinase 5 
(Cdk5) (Agarwal-Mawal and Paudel, 2001; Mortini et al., 2004), CKII and mitogen-
activated protein kinase (MAPK) (Wang et al., 1995). Hence, the absence of the Thr73 in 
I-2L may be indicative of an alternative mechanism for the inhibitory control of PP1 
holoenzyme that rule out the phosphorylation by GSK-3. Another difference is the 
substitution of Ser by Arg at the position 87, which may alter the regulation by CKII and 
subsequently, the regulation of PP1 holoenzyme interaction with other proteins such as 
Nek2 (Fardilha et al., 2004; Wu et al., 2007).  
 
Figure 12: Alignment of predicted amino acid sequences of the I-2 and I-2L. Highlighted residues represent 
the residues that differ between I-2 and I-2L (in grey). Highlighted in red are represented the most important 
substitution of Thr73 in I-2 for Pro73 in I-2L.  
 
By searching Prosite and ELM (Puntervoll et al., 2003) for motifs, several 
phosphorylation sites were found in I-2 and I-2L. CKII phosphorylation sites at the Ser121, 
Ser122, Ser130 and Thr193 are common to both proteins. However, a new putative CKII 
phosphorylation site was found at Ser35 in I-2L, whereas the phosphorylation site at Ser87 
is absent (Figure 13), denoting that, when these phosphorylation residues are written in the 
text, we are referring to human I-2 isoform. These results are very intriguing because it has 
been demonstrated that, in the case of I-2, phosphorylation of Ser86 (rabbit I-2 isoform) by 
CKII enhances the subsequent phosphorylation at the Thr72 by GSK-3β (Wang et al., 
1993; 1995), but does not alter the inhibitory activity of I-2. Furthermore, previews studies 
showed that Ser120 and Ser121 phosphorylation sites are important for the binding of 
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GSK-3 (Holmes et al., 1986). There are also three putative phosphorylation sites for the 
Ca
2+
 and phospholipid-activated protein kinase (PKC) at the Ser7, Ser41 and Ser44 for 
both I-2 and I-2L. This kinase has been described so far as a regulator of glycogen 
synthase (Ahmad et al., 1984). Moreover, other sequences important for the formation of 
the PP1-I-2 complex, such the N-terminal SILK-motif (
12
KGILK
16
) (Bollen, 2001; 
Wakula, 2003), the degenerated RVxF-motif (
43
KSQKW
47
) (Bollen et al., 2010) and the C-
terminal FEMKRKLH sequence (Leach et al., 2002) were also identified, which are 
binding domains to PP1c.  
 
Figure 13: Amino acid sequence of inhibitor-2 (I-2) and inhibitor-2L (I-2L). Highlighted residues represent 
important regulatory sites: PKC phosphorylation site (in blue); CKII phosphorylation site (in brown); GSK-3 
and Cdk5 phosphorylation site (in red); KGILK (in yellow); KSQKW (yellow square), EVDE (in grey) and 
FEMKRKLHY (in beige) are binding domain to PP1c. The region depicted in orange represents the most 
highly conserved domain of I-2 and I-2L. 
 
Differences in only 9 amino acids (5%) introduce huge differences in terms of signal 
transduction regulation of these two almost identical proteins I-2/I-2L. This confers 
completely different functions to the complexes PP1-I-2 and PP1-I-2L, specifically in what 
concerns to sperm motility (see Figure 9).  
 
2.2. Peptide fragments predicted from tryptic digestion 
 
The similarities in terms of nucleotide and amino acid sequence between I-2 and I-2L 
are enormous, which make it difficult to distinguish between this two proteins by means of 
molecular and biochemical methods. For instance, the use of antibodies to recognize a 
specific amino acid sequence of one protein will also recognize the other. Concerning the 
nucleotide sequence, there are no sufficient differences to allow the design of specific 
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primers to the corresponding cDNA. For this reason, the strategy adopted pass through the 
treatment of I-2 and I-2L proteins with a proteolytic enzyme, trypsin, to fragment them, 
determining then the sizes of fragments by mass spectrometry (MS). We expected that I-2 
and I-2L originated unique proteolytic fingerprint since the probability of two proteins 
being cleaved into the same number of fragments, each with the same fragment size is 
extremely small. Therefore, this was a fine approach to differentiate both proteins and 
prove the existence of I-2L in vivo. 
By searching Expasy for potential trypsin cleavage sites, several Arg (R) and Lys 
(K) residue cleavage sites were found for the I-2 and I-2L peptide sequence. There are 25 
putative cleavage sites onto the I-2 peptide sequence and 27 possible cleavage sites onto I-
2L peptide sequence (Figure 14). The main difference observed by comparison of the 
predicted fragments size reside in two peptide fragments with the molecular weight of 
2.109 kDa and 1.477 kDa in I-2L instead of 3.625 kDa in I-2, which may be important for 
distinguish I-2L from I-2 by mass spectrometry. This will be further discussed on chapter 
3.  
 
Figure 14: Potential cleavage sites of the trypsin protease mapped onto inhibitor-2 (I-2) and inhibitor-2 like 
(I-2L) protein sequence. The cleavage occurs at the Arginine (R) and Lysine (K) residues at the right side (C-
terminal direction of the marked amino acid). Two peptide fragments with the molecular weight of 2.109 kDa 
and 1.477 kDa in I-2L are predicted instead of 3.625 kDa in I-2.  
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3. Detection and identification of 
I-2L as a novel putative protein 
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3.1. Expression of endogenous I-2/I-2L in human and rat tissues 
 
3.1.1. Introduction 
 
I-2 was first discovered and purified from rabbit skeletal muscle as a protein which 
could bind to PP1c with a molar ratio of 1:1 and inhibit its activity in vitro (Huang and 
Glinsmann, 1976). I-2 was identified as a heat- and acid- stable protein, ubiquitously 
expressed in a variety of tissues including skeletal and cardiac muscles, liver, kidney, brain 
and lung extracts tissues (Park et al., 1994; Roach et al., 1985), testis (Osawa et al., 1996) 
and sperm (Smith et al., 1996). Moreover, it has been demonstrated that I-2 inhibitory 
activity towards PP1 is regulated by phosphorylation at Thr72 (rabbit I-2 isoform) by 
glycogen synthase kinase-3β (GSK-3β). Sakashita et al. (2003) demonstrated by co-
immunoprecipitation in COS-7 cells that GSK-3β associates with PP1c-I-2 complex, and 
phosphorylates I-2 at Thr72 in vivo.  
I-2 is characterized as a small protein consisting of 204 amino acids, with a predicted 
molecular weight of 23 kDa and an isoelectric point of 4.64. I-2L was identified from a 
human testis cDNA library by performing a YTH screen using PP1γ1 as bait, as a clone 
95% identical to I-2, with a predicted molecular weight of 23 kDa and an isoelectric point 
of 4.77. As discussed in Chapter 2, I-2 and I-2L share a remarkable similarity in the full-
length sequences, as well in the regions containing the binding domains to PP1, raising the 
physiological importance of this novel putative PIP.  
To analyze the presence of I-2 in rat cortex, heart, liver, kidney and testis extracts, 
and the presence of I-2/I-2L in human sperm and testis extracts, given that I-2L clone was 
identified from human testis cDNA library, a specific anti-I-2 antibody was used to analyze 
the extracts by immunoblotting, thus determining the expression of the endogenous I-2/I-
2L. The expression of endogenous PP1γ was also analyzed since I-2L was found in the 
YTH screen using PP1γ1 as bait. It was used an anti-PP1γ antibody, which recognizes both 
PP1γ1 (37 kDa) and PP1γ2 (39 kDa) to immunodetect both isoforms. 
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3.1.2. Materials and Methods 
 
3.1.2.1. Human and rat tissues preparation 
 
Rat tissues were obtained from sacrificed animal and immediately frozen on dry 
ice. Frozen rat tissues were resuspended in boiling 1% SDS and sonicated for 30 sec. 
Human testis samples were obtained via the kind efforts of Dr. Jorge Oliveira (IPO, Porto), 
and processed in the same way as the rat tissues.  
Human semen samples were collected from healthy adult man donors by 
masturbation and cryopreservated in liquid nitrogen. The sperm samples had a sperm 
concentration of 107x10
6
 cells/ml, 80% progressive motility and 16% in situ motility, and 
a volume of 4 ml. These samples were kindly provided by Dr. Vladimiro Silva 
(FertiCentro, Coimbra). The frozen ejaculated sperm samples were allowed to liquefy at 
RT before processing. After liquefying, the sperm was extracted from the semen samples 
using Percoll
®
 (Sigma) density gradient centrifugation according to Dravland and 
Mortimer (1985), Mortinover (2000) and Dr. Christopher Barrat personal communication 
(Figure 15).  
 
 
Figure 15: Sperm sample selective washing method using density gradient centrifugation with Percoll
®
 
40%/80% buffered in NCB medium. Gradient obtained before Aǀ and after Bǀ centrifugation (Dr. Christopher 
Barrat personal communication). 
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Briefly, semen samples were layered over 40%/80% stepwise Percoll
®
 gradients, 
buffered with non-capacitating buffer (NCB) (see Table 2 and Appendix), and centrifuged 
at 500 g for 20 min at RT. The supernatants were discarded and the motile sperm 
population was selected according to Figure 15. The sperm pellets were pooled and washed 
twice in 1 ml NCB. The final pellet was resuspended in 150 l of 1% SDS, and afterward 
sonicated during 30 sec.  
The NCB medium prevents the capacitation of spermatozoa in the ejaculate. The 
formulation of NCB medium was done according to Dr. Christopher Barrat personal 
communication, and it differs upon published data (Linhko et al., 2009) in that it contains 
no bicarbonate (HCO3), to prevent activation of adenylyl cyclase (AC). Also, it has lower 
concentration of BSA to prevent cholesterol removal, and it has an increased concentration 
of Hepes to account the reduction of HCO3.  
 
Table 2: Formulation of NCB (non-capacitating buffer) medium.  
Components Concentration (mM) Amount (g/10 ml) Volume (ml) 
CaCl2 1.8 0.027 1 
KCl 5.4 0.040 1 
MgSO4.7H20 0.8 0.020 1 
NaCl 116.4 0.680 1 
NaH2PO4 1.0 0.016 1 
D(+)-glucose 5.6 0.100 1 
Sodium pyruvate 2.7 0.030 1 
Sodium lactate 41.8 0.468 1 
 
NCB was buffered with Hepes (25 mM) and adjusted to pH 7.4. 0.3% BSA was added to the final solution.  
 
3.1.2.2. Protein assay 
 
Total protein measurements were carried out using Pierce’s BCA protein assay kit, 
following the manufacturer’s instructions. The method combines the reduction of Cu2+ to 
Cu
+
 by protein in an alkaline medium (the biuret reaction), with a sensitive colorimetric 
detection of the Cu
+ 
cation using a reagent containing bicinchoninic acid (BCA). The 
purple-colored reaction product of this assay is formed by the chelation of two molecules 
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of BCA with one Cu
+
 ion. This water-soluble complex exhibits a strong absorbance at 562 
nm that is linear with increasing protein concentration over a working range of 20 g/ml to 
2000 g/ml. At least duplicate microtubes per sample were prepared to be assayed with 25 
L of each sample plus 25 L of 1% SDS. Microtubes with standard protein 
concentrations were prepared as described below (Table 3). 
 
Table 3: Standard curve used in the BCA protein assay method 
Standard BSA (l) 10% SDS (l) H2O (l) Protein mass (g) *WR (ml) 
P0 - 5 45 0 1 
P1 1 5 44 2 1 
P2 2 5 43 4 1 
P3 5 5 40 10 1 
P4 10 5 35 20 1 
P5 20 5 25 40 1 
P6 40 5 5 80 1 
 
*WR (working reagent) 
 
The BSA stock solution used had a concentration of 2 mg/ml. The Working 
Reagent (WR) was prepared by mixing BCA reagent A with BCA reagent B in the 
proportion of 50:1. Then, 1 ml of WR was added to each microtube (standards and 
samples) and the microtubes were incubated at 37 ºC for 30 min. Once the tubes cooled to 
RT the absorbance was measured at 562 nm. A standard curve was obtained by plotting 
BSA standard absorbance vs BSA concentration, and used to determine the total protein 
concentration of each sample. 
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3.1.2.3. SDS-PAGE 
 
In SDS polyacrylamide gel electrophoresis (SDS-PAGE) separations were carried 
out using well established methods (Sambrook et al., 1989). The percentage and size of the 
gel used depended on the molecular weight of the proteins being separated in the gel 
(Table 4). In the time course analysis, to visualize the I-2 and PP1γ, with an apparent 
molecular weight around 32 kDa and 37 kDa, respectively, a 10% acrylamide gel was 
used. 
 
Table 4: Composition of the running and stacking gels for SDS-PAGE (mini gels). 
Components Running gel (10%) Stacking gel (3.5%) 
Water 4.2 ml 3.3 ml 
30% Acryl/8% Bisacryl. 3.3 ml 0.6 ml 
4x LGB 2.5 ml --- 
5x UGB --- 1.0 ml 
SDS 10% --- 50 l 
10% APS 50 l 50 l 
TEMED 5 l 5 l 
 
The 10% running gel was prepared by sequentially adding the components 
indicated on Table 4 (APS and TEMED were added last, as they initiate the polymerizing 
process). The solution was pipetted down the spacer into the gel sandwich, leaving some 
space for the stacking gel. Then, the water was carefully added to cover the top of the gel 
and the gel was allowed to polymerize for 1 hr. The stacking gel was prepared according to 
Table 4. The water was poured out and the stacking gel was added to the sandwich; a comb 
was inserted and the gel was allowed to polymerize for 30 min. 
After the gel polymerization, the combs were removed, and the wells filled with 
running buffer. The samples previously prepared were carefully applied into the wells. The 
gel run for 2 hr at 100 V until bromophenol blue from the LB reached the bottom. 
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3.1.2.4. Immunoblotting 
 
For immunoblotting, the tank transfer system was used as follows: 3MM blotter 
paper was cut to fit the transfer cassette and a nitrocellulose membrane of the gel size was 
also cut. The gel was removed from the electrophoresis device and the stacking gel 
removed and discarded. The transfer sandwich was assembled under transfer buffer to 
avoid trapping air bubbles. The cassette was placed in the transfer device filled with 
transfer buffer. Transfer was allowed to proceed for 2 hr at 200 mA. Afterwards, the 
transfer cassettes were disassembled; the membrane carefully removed and allowed to air 
dry prior to further manipulations.  
The immunodetection was carried by enhanced chemiluminescence (ECL). 
ECL
TM 
(Amersham) is a light emitting non-radioactive method for the detection of 
immobilized antigens, conjugated directly or indirectly with horseradish peroxidase-
labelled antibodies.  
In order to visualize the proteins, the blots were probed with a polyclonal anti-I-2 
antibody (see section 3.1.2.5), which recognizes the I-2/I-2L proteins. The membranes 
were soaked in 1xTBS for 5 min. Non-specific binding sites were blocked by immersing 
the membrane in 3% low fat milk in 1xTBST for 1 hr. After washing with 1xTBST, the 
membrane was incubated with a solution of the primary antibody (anti-I-2; 1:100), diluted 
in 3% low fat milk in 1xTBST for 2 hr with shaking. After three washes of 10 min each in 
1xTBST, the membrane was incubated with a solution of the anti-sheep secondary 
antibody diluted for ECL (1:1000) in 3% low fat milk in 1xTBST for 2 hr with shaking. 
The membrane was then washed 3 times with 1xTBST for 10 min. Subsequently, the 
membrane was incubated for 1 min with the ECL detection solution (a mixture of equal 
volumes of solution 1 and solution 2 from the ECL kit (Amersham), approximately 0.125 
ml/cm
2
 membrane). Inside the dark room, the membrane was gently wrapped with cling-
film, eliminating all air bubbles and placed in a film cassette and an autoradiography film 
(XAR-5 film, KODAK) was placed on the top. The cassette was closed and the blot 
exposed for 10 min. The film was then removed and developed in a developing solution, 
washed in water and fixed in fixing solution.  
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To immunodetect PP1γ, the same membrane was washed three times with 1xTBS-T 
during 30 minutes and then blocked in 3% low fat milk in 1xTBST for 1 hr before incubate 
the membrane with a solution of the primary antibody (CBC3C anti-PP1γ; 1:1000), diluted 
in 3% low fat milk in 1xTBST, for 2 hr with shaking. After this period, three washes of 10 
min each in 1xTBST were done, and the membrane was next incubated with a solution of 
the anti-rabbit secondary antibody diluted for ECL (1:5000) in 3% low fat milk in 1xTBST 
for 2 hr with shaking. This membrane was prepared for ECL detection following the 
procedure described before.  
As a control, this membrane was also incubated with anti-β-tubulin antibody, to 
determine if the quantity of protein loaded into the gel was equal for all samples. The same 
membrane was washed three times during 10 min with 1xTBST, blocked in 3% low fat 
milk in 1xTBST for 1 hr before incubate the membrane with a solution of the primary 
antibody (anti-β-tubulin; 1:500), diluted in 3% low fat milk in 1xTBST for 2 hr with 
shaking. After this period, three washes of 10 min each in 1xTBST were done, and the 
membrane was then incubated with a solution of the anti-mouse fluorescein isothiocyanate 
(FITC) conjugated antibody (1:1000) in 3% low fat milk in 1xTBST for 2 hr with shaking. 
The membrane was then washed twice with 1xTBST for 10 min and 1xTBS for 1 min and 
the membrane observed in a Odyssey
®
 infrared imaging system version 2.1 (LI-COR 
Biosciences, USA). 
 
3.1.2.5. Anti-I-2 antibody  
 
The anti-I-2 antibody was previously purified in our laboratory by Wenjuan Wu, by 
affinity column purification of antibody-containing sheep serum, kingly provided by Dr. 
David Brautigan. As the concentration of the antibody was too low (0.04 mg/ml), the anti-
I-2 antibody was then concentrated using a Centripep
®
 (Millipore) centrifugal filter device 
following the manufacture’s procedure.  
The concentration of anti-I-2 antibody was measured at 280 nm (1.4 OD=1 mg/ml) 
and corresponded to 0.5 mg/ml. Afterwards, the antibody was diluted (1:100) in 3% low 
fat milk in 1xTBST and an immunoblot (see section 3.1.3.1) was performed using His-
tagged I-2 that was expressed in Escherichia coli and purified in our laboratory by Ana 
Vintém.  
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3.1.3. Results 
 
3.1.3.1. Detection of purified His-tagged I-2 with anti-I-2 antibody 
 
In order to test the polyclonal anti-I-2 antibody (0.5 mg/ml) affinity to I-2, an 
immunoblot was performed using different amounts of purified I-2-His. As shown in 
Figure 16, a dilution (1:100) of anti-I-2 antibody was used to recognize 100 ng, 10 ng, 1 ng 
and 0.1 ng of purified I-2 His, being the fusion protein identified at 37 kDa. Thus, this anti-
I-2 antibody (1:100) was used for further experiments.  
 
Figure 16: Immunoblot analysis of purified I-2-His (1-4) using the polyclonal anti-I-2 antibody (1:100). 1, I-
2-His (100 ng); 2, I-2-His (10 ng); 3, I-2-His (1 ng); 4, I-2-His (0.1 ng). 
 
3.1.3.2. Tissue distribution of I-2/I-2L proteins 
 
The tissue distribution of I-2 and I-2/I-2L was evaluated by immunoblot analysis of 
different rat tissues, and human testis and sperm. From Figure 17a it was evident that I-2/I-
2L proteins were present in human and rat testis and in human sperm. Besides these 
tissues, I-2 was also expressed in rat cortex, heart, kidney and liver, but it seems to be less 
expressed in liver. I-2/I-2L, intrinsically unstructured proteins (IUPs), run in the SDS-
PAGE gel with a higher molecular weight (32 kDa) than the predicted (23 kDa).  
Concomitantly, the tissue distribution of PP1γ is shown in Figure 17b, since PP1γ 
isoforms interact with I-2 in several tissues. It was reported before that the levels of PP1γ2 
activity are higher in testis and sperm allied with the role of I-2 in sperm maturation. 
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Furthermore, I-2L was shown to putatively interact with PP1γ1 isoform in testis (see 
Chapter 2). Anti-PP1γ antibody was used to immunodetect both PP1γ1 and PP1γ2 in 
several tissues. In rat tissues, the levels of expression for these PP1γ isoforms were higher 
for cortex, kidney and testis, and lower for heart and liver. It is also apparent that the 
amount of PP1γ in testis is higher in rat testis than in human testis. Evaluating the levels of 
expression in human sperm and testis, it is evident that sperm contains more PP1γ than 
testis.  
These results are intriguing when the levels of expression of I-2/I-2L and PP1γ 
isoforms are compared, since these results indicated that, in testis, low expression of PP1γ 
isoforms correlates with high levels of expression of I-2/I-2L, and high expression of PP1γ 
isoforms, mainly PP1γ2, correlates with lower expression of I-2/I-2L. These curious results 
will be discussed bellow (see section 3.1.4).  
 
Figure 17: I-2 and I-2/I-2L tissues screen. Aǀ A multiple tissue screening (25 µg) of I-2 was performed using 
anti-I-2 (1:100) antibody, and purified I-2-His (50 ng) was used as positive control. The predicted molecular 
weight of I-2/I-2L is 23 kDa. Bǀ The same membrane was incubated with a C-terminus anti-PP1γ antibody 
(1:1000) to perform a PP1γ tissue screening. The molecular weight of PP1γ1 and PP1γ2 is 37 kDa and 39 
kDa, respectively. Cǀ The β-tubulin was used as control. I-2/I-2L run in the SDS-PAGE gel with an apparent 
molecular weight of 32 kDa.  
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3.1.4. Discussion 
 
I-2L was identified in an YTH screen, using PP1γ1 as bait and a human testis cDNA 
library, as a putative PP1γ1 interactor, very similar to I-2, an ancient and highly conserved 
inhibitor of PP1. Subsequently, a bioinformatics analysis of the encoded protein revealed 
several physiologically relevant features of the protein (see Chapter 2).  
Further, we performed an immunoblot analysis of several rat tissues, and human 
testis and sperm. These results showed that I-2/I-2L were present in most of the analyzed 
tissues (Figure 17). Expression of I-2/I-2L was observed in human testis and sperm. These 
results suggested that I-2/I-2L have an important role in the inhibition of PP1γ2, which is 
also present, as indicated by the results, in sperm. In contrast, low levels of expression of I-
2/I-2L and PP1γ isoforms were detected in rat liver.  
Several studies indicated that I-2 has an important physiological role in several 
tissues. For instance, Terry-Lorenzo et al. (2002) have shown from rat brain extracts that I-
2 binds to PP1 and several other binding proteins forming a multiprotein complex. For 
example PP1-I-2 binds to actin-binding proteins, neurabin I and neurabin II/spinophilin, 
which are neuronal actin-binding proteins that targeted PP1 to F-actin and regulate cell 
morphology. I-2 was also identified in cardiomyocytes, as reported in several studies 
(Gupta et al., 2005; Yamada et al., 2006). Studies in vivo with mice overexpressing I-2 
demonstrated that PP1 activity is decreased concomitantly with the enhanced contractility 
in heart, suggesting that I-2 improves the cardiac performance (Kirchhefer et al., 2005). I-2 
has also been previously identified to be largely expressed in rat kidney extracts, 
accordantly with the earlier reports with other mammalian kidney extracts (Roach et al., 
1985). Concerning to the expression of I-2 in rat liver, the results indicated that I-2 has 
lower expression in liver, contrary to the results reported by Roach et al. (1985) and by 
Park et al. (1994) with rabbit liver extracts. In addition, previous results from our 
laboratory have demonstrated that I-2 and PP1γ1 isoforms have low expression in rat liver 
extracts (unpublished results). 
The presence of I-2/I-2L in rat and human testis and in human sperm was confirmed 
by immunoblotting analysis, as well as the presence of PP1γ isoforms, specifically PP1γ2. 
Indeed, I-2/I-2L and PP1γ2 are expressed in rat testis, and in human testis and sperm. The 
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expression of I-2 and PP1γ2 in germ tissues has been documented previously (Chakrabarti 
et al., 2007; Osawa et al., 1996). PP1γ2 is expressed during germ cell differentiation in 
testis and during spermatozoa maturation, and its activity is related with I-2-like activity 
that was reported to exist in human sperm (Chakrabarti et al., 2007; Huang and 
Vijayaraghavan, 2004; Vijayaraghavan et al., 1996). Our results indicated that the ratio 
PP1γ2-(I-2/I-2L) is different in human testis and sperm probably meaning differences in 
the complex regulation. Moreover, sperm samples with different motility parameters 
(unpublished results) also present different PP1γ2-(I-2/I-2L) ratios. These ratios might 
serve as a diagnostic tool to male infertility. 
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3.2. Co-localization of I-2/I-2L with PP1γ2 isoform in human spermatozoa 
 
3.2.1. Introduction 
 
In order to determine if PP1γ2 and I-2/I-2L co-localize in human sperm cells, 
subcellular localization studies were carried out. Human semen has a corpuscular and 
liquid component. The corpuscular compartments are spermatozoa, immature germ cells, 
sloughed-off epithelial cells from the seminiferous tubules, spermatophages, cytoplasmic 
droplets and leukocytes. Cells of the testis, epididymis and accessory glands secrete the 
liquid components of the seminal plasma (De Jonge and Barratt, 2006). Ejaculated 
spermatozoa are motile but they need to undergo capacitation in the female genital tract 
before they can fertilize an oocyte (Turner, 2003). The epididymal sperm maturation and 
development of sperm motility in the epididymal tract involves changes in PP1γ2 activity, 
which is the major PP1γ isoform in sperm (Huang and Vijayaraghavan, 2004). In vitro 
studies indicated that PP1γ2 is active in bovine, monkey, macaque and human caput 
spermatozoa and its activity decreases in caudal spermatozoa (Smith et al., 1996; 1999). 
This regulation is triggered by I-2/I-2L that is a highly expressed inhibitor in human sperm, 
as demonstrated before (section 3.1.3.2).  
Thus, to allow the analysis of the endogenous I-2/I-2L expression and subcellular 
distribution in human spermatozoa and its co-localization with endogenous PP1γ2 by 
immunocytochemistry, specific antibodies were used which recognizes specifically I-2/I-
2L and PP1γ2 isoform.  
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3.2.2. Material and Methods 
 
3.2.2.1. Immunocytochemistry procedure 
 
Sperm cells were prepared by selective washing using Percoll
® 
gradient, following 
the protocol described previously. To the final pellet was added 300 µl of a solution 
containing NCB medium (Table 2) in 0.3% BSA. The human semen sample was kingly 
provided by Dr. Vladimiro Silva (FertiCentro, Coimbra), obtained from a healthy adult 
man volunteer by masturbation and cryopreserved in liquid nitrogen. The sperm sample 
had a sperm concentration of 36x10
6
 cells/ml, a 68% progressive motility and 4% in situ 
motility, and a volume of 2 ml.  
An aliquot of sperm cells (25 µl) was placed onto a glass coverslip pre-coated with 
100 g/ml poly-L-ornithine, and dried at RT, in a six well plate containing one coverslip 
per well. To each well was gently added 1 ml of 4% paraformaldehyde in PBS and left to 
stand for 10 min. Subsequently, sperm cells were washed twice with 1 ml 1xPBS for 10 
min. For sperm cells permeabilization, 1 ml of 1:1 methanol/acetone solution was added 
for 2 min and then washed twice with 1 ml 1xPBS for 10 min. The cells were blocked out 
for 1 hr with 3% BSA in 1xPBS, and then were incubated with primary antibody for 2 
hours at RT. After three washes with 1xPBS, the secondary antibody was added and the 
coverslips incubated for 2 hr. Finally, three washes with 1xPBS were performed and 
coverslips were mounted on microscope glass slides with one drop of anti-fading reagent 
containing DAPI for nucleic acid staining (Vectashield, Vector Laboratories). 
Photographies were acquired using an epifluorescence microscope equipped with 
appropriate software (Olympus IX81).  
The primary antibodies used were the rabbit polyclonal anti-PP1γ2 (G502; 1:1000) 
and the sheep polyclonal anti-I-2 antibody (1:100). The secondary antibodies used were the 
anti-sheep fluorescein isothiocyanate (FITC) conjugated antibody (1:50) and the anti-rabbit 
Texas Red conjugated antibody (1:300). The antibodies were diluted in 3% BSA in 1xPBS. 
The antibodies were added subsequently, according to the description in Figure 18.  
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Figure 18: Immunocytochemistry procedure for subcellular localization of PP1γ2 and I-2/I-2L in human 
sperm. The primary and secondary antibodies used were added to the sperm sample sequentially. Aǀ The anti-
PP1γ2 antibody (G502; 1:1000) was first added to the sperm sample. Bǀ The secondary anti-rabbit Texas Red 
conjugated antibody (1:300) was added after the anti-PP1γ2 antibody. The dashed blue line represents the 
washing procedure before the incubation with the anti-I-2 antibody. Cǀ The anti-I-2 antibody (1:100) was 
thirdly added to the sperm sample after the washing procedure. Dǀ The secondary anti-sheep fluorescein 
isothiocyanate (FITC) conjugated antibody (1:50) was added after the anti-I-2 antibody.  
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3.2.3. Results 
 
Immunofluorescence was used to localize I-2/I-2L and PP1γ2 within human 
spermatozoa. As seen in Figure 19a, in morphological normal spermatozoa, PP1γ2 and I-
2/I-2L co-localize at the principal-piece and middle-piece of flagellum and at the equatorial 
and postacrosomal segment of the head region. The staining appears to be specific since 
there was no fluorescence observed when the primary antibodies were omitted (data not 
shown).  
Co-localization of I-2/I-2L and PP1γ2 in abnormal human spermatozoa was also 
evaluated (Figure 19b-e). In abnormal tail spermatozoa (Figure 19b), co-localization of I-
2/I-2L with PP1γ2 was detected at the middle- and principal- piece of flagellum and at the 
postacrosomal region of the spermatozoa head. Interestingly, the percentage of co-
localization seems lower when compared to morphological normal spermatozoa. In 
middle-piece abnormal spermatozoa (Figure 19c), co-localization of I-2/I-2L with PP1γ2 
was detected in the entire length of the flagellum and in the equatorial region of the 
spermatozoa head. Comparatively, in abnormal head spermatozoa (Figure19d), I-2/I-2L 
co-localize with PP1γ2 in the principal-piece and middle-piece of flagellum, and in the 
equatorial and postacrosomal segment of the head region, resembling normal spermatozoa 
(Figure 19a). More interestingly, was the staining in spermatozoa with multiple 
abnormalities (Figure 19e). I-2/I-2L was absent from the tail. PP1γ2 and I-2/I-2L staining 
in the head was diffuse and co-localize.  
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Figure 19: Co-localization of PP1γ2 and I-2/I-2L in morphologically normal and abnormal spermatozoa. 
Human spermatozoa were labeled with anti-PP1γ2 and anti-I-2 antibodies, and specific secondary antibodies 
conjugated with Texas Red and FITC fluorophores, respectively. Aǀ Normal spermatozoa. Bǀ Abnormal tail 
spermatozoa. Cǀ Abnormal middle-piece spermatozoa. Dǀ Abnormal head spermatozoa. Eǀ Multiple 
abnormalities spermatozoa. Phase contrast (PH). Scale bar = 20 µm. 
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3.2.4. Discussion 
 
PP1γ1 and PP1γ2 isoforms originated from alternative splice of the PP1γ gene are 
differentially expressed. Unlike PP1γ2 that is sperm- and testis- enriched, PP1γ1 is 
expressed in various tissues (da Cruz e Silva et al., 1995; Huang and Vijayaraghavan, 
2004; Smith et al., 1996). Among others, I-2-Like activity is an important inhibitor of 
PP1γ2 activity in ejaculated human sperm (Smith et al., 1999). Through 
immunocytochemitry, using an anti-I-2 antibody, which recognizes I-2/I-2L proteins, we 
showed that in human sperm, PP1γ2 co-localizes endogenously with I-2/I-2L, and those 
co-localize in the sperm tail, specifically in the middle-piece and the principal-piece 
(Figure 19), consistent with the regulatory role for PP1γ2 and I-2/I-2L in the control of 
sperm motility. Co-localization also occurs in the spermatozoa postacrosomal and 
equatorial segment of the head region, suggesting a role in the acrosome reaction. The 
expression of PP1γ2 during cell differentiation in testis has been well documented 
(Chakrabarti et al., 2007; Osawa et al., 1996), and the PP1 involvement in the onset of 
hyperactivated motility and the acrosome reaction was also reported (Breitbart, 2002; 
Küpker et al., 1998; Si and Okuno, 1999; Turner, 2003).  
PP1γ2 co-localization with I-2/I-2L in spermatozoa flagellum may also indicate the 
importance of PP1γ2-(I-2/I-2L) complex in sperm morphogenesis, in addition to its role in 
motility. Chakrabarti and collaborators (2007) demonstrated in vivo, using Ppp1cc-null 
mice, that PP1γ2 is involved in sperm tail morphogenesis, and that the absence of this 
protein lead to the reduction in the levels of postmeiotic proteins such as AKAP4 and 
sds22 (Huang et al., 2002), that regulate PP1γ2, and are associated with sperm tail 
development and function. The distribution pattern of PP1γ2 and I-2/I-2L in abnormal 
spermatozoa was very intriguing when compared to normal spermatozoa, where PP1γ2 co-
localizes with I-2/I-2L only in the middle- and principal- piece of flagellum compared to 
the previous. Accordingly, testicular sperm tails from Ppp1cc-null mice demonstrated a 
variety of abnormalities in both middle and principal pieces, suggesting some deregulation 
of PP1γ2-(I-2/I-2L) complex in sperm differentiation and morphogenesis (Chakrabarti et 
al., 2007). Additionally, it has been demonstrated that PP1γ2 and I-2 expression levels 
increase significantly during spermiogenesis (Chakrabarti et al., 2007; Osawa et al., 1996). 
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This is another indication of the importance of PP1γ2-(I-2/I-2L) complex in sperm 
development. 
The results presented in this chapter indicated that the role of PP1γ2-(I-2/I-2L) 
complex in spermatozoa morphogenesis and motility is possibly related with the 
arrangement of the flagellum. Chakrabarti et al. (2007) demonstrated that tail 
abnormalities in Ppp1cc-null sperm include middle-pieces that had disorganized 
mitochondrial sheaths or were thinner than principal pieces due to the absence of 
mitochondrial sheaths. Wang and Brautigan (2008) demonstrated the importance of I-2 in 
the acetylation of microtubules that make up the axoneme contributing for the stability of 
the structure, in I-2 knockdown cells by siRNA. PP1 has been localized in 
Chlamydomonas axonemal central pair apparatus (Yang et al., 2000). Several evidences 
support a role for PP1γ2-(I-2/I-2L) complex in the regulation of sperm motility by being 
involved in sperm tail dynamics (Figure 20). Indeed, PP1γ2 co-localizes with I-2/I-2L in 
equatorial and postacrosomal segment of the head, middle- and principal- piece of flagella 
(in grey, Figure 20) in morphologically normal spermatozoa. When defects are present, 
PP1γ2-(I-2/I-2L) expression is altered and presumably also the complex functions. In the 
more extreme case, the spermatozoa with multiple abnormalities, I-2/I-2L are no longer 
expressed in the tail probably meaning that PP1γ2 is not being inhibited and consequently 
active. This will lead to an immotile sperm cell (Vijayaraghavan et al., 1996; 2000). 
Here we propose a putative diagnostic tool to compare at the molecular level 
morphologically different sperm cells based on the co-expression of PP1γ2-(I-2/I-2L).  
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Figure 20: Schematic representation of the mammalian spermatozoa and the ultra-structure of flagellum Aǀ 
Mammalian sperm is composed of head divided into acrosome, equatorial and postacrosomal regions, and 
flagella is divided into middle-piece, principal-piece and end-piece. In grey are represented the regions where 
PP1γ2 co-localize with I-2/I-2L (equatorial and postacrosomal segment of the head, middle- and principal-
piece of flagellum). Bǀ-Dǀ Schematic cross-section through a representative segment of flagellum, 
highlighting the middle-piece Bǀ, principal-piece Cǀ, end-piece Dǀ. Along the flagellum, the axonemal 
components (OMDA) arranged 9+2 (9 outer microtubules doublets and the central pair of microtubules 
doublets) are unchanged but the mitochondrial sheath (MS) is only present in the middle-piece region 
(adapted from Turner, 2003).  
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3.3.  Immunoprecipitation of I-2/I-2L and mass spectrometry analysis 
 
3.3.1. Introduction 
 
Through immunoblot analysis (see section 3.1.3.2) we showed that PP1γ2 and I-2/I-
2L are expressed in human testis and sperm, and through immunocytochemistry (see 
section 3.2.3) we showed that in human sperm PP1γ2 co-localizes endogenously with I-2/I-
2L in sperm tail. Thus, the results are consistent with the occurrence of I-2/I-2L in sperm, 
previously described, but did not allow us to reach any conclusions regarding the 
occurrence of I-2L protein, since the methods used employed antibodies, specifically anti-
I-2 antibody, that may recognize both I-2/I-2L proteins. Certainly, if I-2L is expressed, it 
interacts endogenously with PP1γ2 in human spermatozoa, but this interaction does not 
occur in the terminal end of flagellum and the acrosomal region of the head, as suggested 
by previous results (Figure 19 and 20) because the results have shown the presence of I-
2/I-2L in the equatorial and postacrosomal segments of the head, and the middle- and 
principal pieces- of the flagellum.  
To analyze if I-2/I-2L and PP1γ2 interacts, several experiments were previously 
performed in our laboratory by Ana Vintém and Wenjuan Wu. However these results do 
not guarantee the existence in vivo of I-2L protein. Nevertheless, the in vitro binding of 
purified I-2L with both PP1γ isoforms was confirmed by overlay. Also Co-IP from human 
sperm confirmed PP1γ2 and I-2/I-2L interaction (data not shown).  
With the proposal of confirming that I-2L is expressed and interacts with PP1γ2 in 
human sperm, and address the physiological relevance in vivo of PP1γ2-I-2L interaction, 
we attempted to immunoprecipitate I-2/I-2L from human sperm extracts, to analyze the 
immunoprecipitates (IP) by mass spectrometry (MS), thus trying to identify a specific 
peptide profile (Lodge et al., 2007). To that end, the immunoprecipitation with anti-I-2 
antibody followed by immunoblot analysis of the IP and in-gel extraction of the band 
corresponding to I-2/I-2L was performed. Optimization of immunoprecipitation protocol 
for the anti-I-2 antibody and target proteins (I-2/I-2L) was done in order to obtain a 
successful I-2/I-2L protein capture due to the fact that some antibodies may show a 
reduced antigen-binding efficiency for immunoprecipitation assay (Sambrook et al., 1989).  
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 56 
 
 
3.3.2. Material and Methods 
 
3.3.2.1. Optimization of immunoprecipitation protocol 
 
Purified I-2-His (100 ng) was pre-incubated with 2 l of anti-I-2 antibody (0.5 
mg/ml) in 500 l of 3% BSA in 1xPBS buffer for 1h at 4 ºC with rotation. After this 
period, 50 l of Protein G Sepharose slurry (Amersham) was added, and the mixture was 
incubated overnight at 4 ºC with agitation. Protein G Sepharose slurry was previously 
prepared by centrifugation during 1 min at 4 ºC at 10.000 g and by washing the pellet three 
times with 3% BSA in 1xPBS buffer at 4 ºC.  
After centrifuging the sample for 1 min at 4 ºC at 10.000 g, the supernatant was 
removed and the pellet washed twice for 10 min with 500 l of 3% BSA in 1% PBS buffer. 
The pellet was resuspended in 25 l of electrophoresis buffer (loading buffer for SDS-
PAGE) and before loading, the IgG of the sample was eluted from protein G by two 
alternative methods: by the addition of 0.1 M glycine buffer, pH 3.0 as elution buffer 
followed by the neutralization of the sample with 1M Tris-HCl, pH 9.0, or by heating the 
sample for 3 min at 90 ºC. The sample was briefly centrifuged to pellet the Sepharose 
beads and the supernatant applied to the gel.  
For the Dynabeads
®
 Protein G (Invitrogen) protocol, 2 l of I-2 antibody (0.5 
mg/ml) diluted in 200 l 3% BSA in 1xPBS buffer was directly added to 100 l 
Dynabeads (3.0 mg), previously prepared by placing the tube containing the Dynabeads on 
the magnet (Dynal MPC
®
) to separate the beads from the supplied solution, and by 
washing the pellet twice with 200 l of 3% BSA in 1xPBS buffer. The mixture was 
incubated with rotation during 1 h at 4 ºC, and the tube was then placed on the magnet and 
the supernatant removed. The Dynabeads-Ab complex was resuspended in 200 l 3% BSA 
in 1xPBS buffer, and 100 ng of purified I-2-His were added and incubated overnight with 
rotation at 4 ºC to allow the binding to the Dynabeads-Ab complex. After this period, the 
tube was placed on the magnet, the supernatant was removed and the pellet washed three 
times using 200 l 3% BSA in 1xPBS buffer for each wash. The pellet was resuspended in 
100 l 3% BSA in 1xPBS buffer and transferred to a clean tube. Finally, the tube was 
placed on the magnet, the supernatant was removed and the denaturing elution was 
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performed by the addition of 1/4 volume of electrophoresis buffer (loading buffer for SDS-
PAGE) and before loading onto the gel, the IgG of the sample was eluted from protein G 
by heat for 10 min at 70 ºC.  
 
3.3.2.2. Immunoprecipitation procedure  
 
After selective washing of the semen sample by Percoll
®
 centrifugation gradient, 
following the procedure described in section 3.1.2.1, the pellet containing motile 
spermatozoa was resuspended in 500 µl of 1xPBS containing a protease inhibitor cocktail 
(see Appendix). The sample was sonicated for 5 sec three times, intercalating the samples 
in order not to over-heat them. After BCA protein quantification described before in 
section 3.1.2.1 mass normalized lysates were pre-cleared with 20 µl of Dynabeads
®
 Protein 
G (Invitrogen), previously prepared in 100 µl of 1% PBS in 3% BSA, for 1 hr at 4ºC with 
agitation. At the same time, the remaining volume (80 µl) of Dynabeads
®
 Protein G 
(Invitrogen) were also pre-incubated with 2 µl of anti-I-2 antibody (0.5 mg/ml),  during 1 
hr at 4 ºC with rotation. The Dynabeads
®
 Protein G used was previously prepared taking 
into account the protocol for the optimized immunoprecipitation (see section 3.3.2.1). 
After incubation, the tubes containing the samples were placed on the magnet (Dynal 
MPC
®
) and processed as follows: the supernatant from the tube containing the Dynabeads
®
 
Protein G-Ab complex was discarded and the supernatant from the pre-clearance was 
added to the prior tube. This mixture was then incubated overnight with shaking at 4 ºC. 
Afterward, the tube containing the mixture was placed on the magnet and washed three 
times with 1xPBS in 3% BSA for 10 minutes with agitation at 4 ºC. Before the last wash, 
the mixture was transferred into a new tube, and after the last wash the supernatant was 
discarded and the beads were resuspended in 100 µl of loading buffer/1% SDS and boiled 
for 10 minutes at 70 ºC. The lysates from the same semen sample were also collected (25 
µg) and the appropriated volume of 10% SDS was added to obtain a final concentration of 
1% SDS. Then, they were boiled for 10 min and frozen.  
Immunoprecipitates and lysates were separated by 10% SDS-PAGE. The lysates and 
40 µl of the immunoprecipitate were loaded in one of two gels, and the remaining 
immunoprecipitate (60 µl) was loaded in the other gel. The first gel was transferred to a 
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nitrocellulose membrane that was then incubated with anti-I-2 antibody (1:100) and the 
second gel was stained with Coomassie blue colloidal (see section 3.3.2.3).  
 
3.3.2.3. Coomassie blue colloidal staining and I-2/I-2L in-gel extraction 
 
Coomassie blue colloidal staining is based on non-specific binding of Coomassie 
blue dye to proteins. Separated proteins are simultaneously fixed and staining in the gel 
and then distained to remove the background prior to drying. The proteins are detected as 
blue bands on a clear background.  
The gel containing the immunoprecipitated was fixed by placing it in the fixation 
solution during 1 hour. After the gel was fixed, the gel was washed with distillated water 
and then transferred to the Coomassie blue colloidal staining solution and stained for 1 hr 
with agitation. After the gel was stained, the gel was washed with distillated water and 
afterwards distained with distain solution for 1 hr. After the first hour of distaining, fresh 
distaining solution was added and the gel was distained overnight.  
In view of the fact that I-2 and I-2L were immunoprecipitated together, because 
anti-I-2 antibody recognizes both proteins, a single band was stained corresponding to I-
2/I-2L proteins with the molecular weight of 32 kDa. This single band was extracted 
directly from the gel using one spatula, and the sample was stored at -80 ºC for further 
mass spectrometry analysis.  
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3.3.3. Results 
 
In order to confirm the expression of I-2/I-2L in vivo, immunoprecipitation assay was 
carried out using human sperm extracts. Immunoprecipitation was performed using anti-I-2 
antibody. Firstly, the immunoprecipitation assay protocol was optimized for the anti-I-2 
antibody and purified His-tagged I-2, using Protein G Sepharose slurry (Figure 21). The 
immunoblot analysis indicated that using different elution conditions of the IgG from 
protein G, by heating the sample (Figure 21a) or by adding an acid solution (Figure 21b), 
the results are similar. Comparing with the control, corresponding to 100 ng of purified I-
2-His, the amount of I-2 immunoprecipitated was also very small. In addition, a non-
specific band with 32 kDa corresponding to the protein G was seen in the blot, indicating 
that Protein G, covalently linked to the beads slurry, detaches from the beads, possible 
during the boiling and acid elution of the sample. Similar results were obtained using 
Protein A Sepharose slurry, where a non-specific band with 42 kDa, corresponding to the 
protein A, was seen in the blot (data not shown).  
 
Figure 21: Immunoblot analysis of purified I-2-His immunoprecipitated using Protein G Sepharose slurry 
and anti-I-2 antibody, and immunoblotted with anti-I-2 antibody. Immunoblot comparison of the IgG eluted 
from protein G by heat at 70 ºC A and by glycin/tris-HCl elution buffer B. 1, I-2-His (100 ng); 2-4, 
washes; 5, I-2-His immunoprecipitated with anti-I-2 antibody. 
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Because the immunoprecipitation of purified I-2-His was not successful, we tried to 
apply the immunoprecipitation protocol using Dynabeads
®
 Protein G instead of Protein G 
Sepharose slurry. The blotting analysis revealed that I-2-His was more successfully 
immunoprecipitated (Figure 22), despite the loss of I-2 protein during the washing 
procedure. In the view of these results, the Dynabeads
®
 Protein G procedure will be used 
for the immunoprecipitation of I-2/I-2L from human sperm samples.  
 
Figure 22: Immunoblot analysis of purified I-2-His immunoprecipitated with Dynabeads
®
 Protein G and 
anti-I-2 antibody, and immunoblotted with anti-I-2 antibody. 1, I-2-His (100 ng); 2, I-2-His 
immunoprecipitated with anti-I-2 antibody; 3-4, washes.  
 
In order to perceive if it was possible to recover the I-2 and I-2L peptides by mass 
spectrometry, purified I-2-His (200 ng) and purified I-2L proteins (200 ng), were separated 
in a 10% SDS-PAGE gel, transferred to a nitrocellulose membrane and revealed with ECL 
(Figure 23a) or stained with Coomassie blue colloidal (Figure 23b). Then, the band was 
extracted from the gel for further mass spectrometry analysis. The results indicated that, as 
expected, purified I-2-His run in the SDS gel with approximately 37 kDa and purified I-2L 
(previously purified in our laboratory by Ana Vintém) run in the SDS gel with 32 kDa. The 
amount of I-2 or I-2L proteins for the visualization and in-gel extraction of the bands 
indicated for further mass spectrometry analysis was 100 ng.  
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Figure 23: AImmunoblot analysis of purified I-2-His and purified I-2L using anti-I-2 antibody. 1, I-2-His 
(200 ng); 2, I-2L (200 ng). BCoomassie colloidal blue stained and in-gel extraction of I-2/I-2L band. 1, 
Precision Plus Protein™ (5 ng); 2, I-2-His (200 ng); 3, I-2L (200 ng). 
 
Taking into account the previous results with purified I-2-His and purified I-2L, 
sperm cell lysates and immunoprecipitates (IP) were performed using anti-I-2 antibody and 
these were separated in two different 10% SDS-PAGE gels. One of the gels, loaded with 
the sperm cell lysates and 40 µl of the IP, was transferred to a nitrocellulose membrane, 
immunoblotted with anti-I-2 antibody and developed by ECL (Figure 24a). The other gel 
was loaded with 60 µl of the IP and stained with Coomassie blue colloidal staining solution 
(Figure 24b). Upon immunoprecipitation with anti-I-2 antibody, a strong band bellow 37 
kDa, corresponding to I-2/I-2L protein (32 kDa), was detected by immunoblotting with 
anti-I-2 antibody (Figure 24a). These results indicated and confirmed that I-2/I-2L is 
expressed in vivo in human sperm, and that can be successfully isolated and purified from 
the human sperm extract. None I-2/I-2L was detected in the preclearance and washes, 
indicating that I-2/I-2L present in the sample were immunoprecipitated altogether. These 
results also demonstrated that I-2/I-2L immunoprecipitated from human sperm extracts run 
in the SDS gel as a co-migrating species, that are visualized in the immunoblot as a band 
corresponding to a molecular weight of 32 kDa. All the remaining IP was separated in the 
Coomassie blue staining gel. However, the band obtained from the staining at 32 kDa, 
corresponding to I-2/I-2L proteins, was very weak, but still visible, indicating that the 
amount of protein present may be sufficient for the mass spectrometry analysis (Figure 
24b). Additionally, a large band of approximately 50 kDa was also detected in the 
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 62 
 
immunoprecipitated corresponding to BSA protein used during the immunoprecipitation 
procedure (Figure 24b).  
 
Figure 24: Isolation and purification of I-2/I-2L from human sperm extract by immunoprecipitation. 
AImmunoblot analysis of human sperm extract immunoprecipitated with anti-I-2 antibody and 
immunoblotted with anti-I-2 antibody. Purified I-2-His (100 ng) and purified I-2L (100 ng) were used as 
controls. PC, preclearance; HS, human sperm lysate; L1-L2, washes; IP, immunoprecipitated I-2/I-2L with 
Dynabeads
®
 Protein G. BCoomassie colloidal blue stained 10% SDS gel containing the immunoprecipitated 
I-2/I-2L (IP) with Dynabeads
®
 Protein G.  
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 63 
 
 
3.3.4. Discussion 
 
Immunoprecipitation is a reliable technique used to isolate and purify a protein of 
interest from a sample containing a complex mixture of proteins that works by the 
formation of antigen-antibody complexes (Sambrook et al., 1989). To address the 
physiological relevance of PP1γ2-I-2L complex, we attempted to demonstrate in vivo that 
I-2L is expressed in human sperm and that it occurs as a PP1γ2 interacting protein in 
human sperm. Immunoprecipitations were performed, first with the purified His-tagged I-2 
and I-2L proteins, to optimize the immunoprecipitation assay protocol, and then with 
human sperm extracts using an anti-I-2 antibody followed by immunoblot analysis using 
anti-I-2 antibody and, in parallel, the analysis and in-gel extraction of the band 
corresponding to I-2/I-2L stained with Coomassie blue colloidal. The extracted bands were 
sent for to MS analysis and the peptides obtained from tryptic digestion compared (see 
section 2.2) in order to validate the amino acid sequence of I-2L obtained from the YTH 
analysis.  
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4. Discussion and Perspectives 
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Protein phosphorylation represents one of the most common post-translational 
modifications in eukaryotes. Protein Serine/Threonine Phosphatase-1 (PP1) catalyzes the 
majority of eukaryotic protein dephosphorylation reactions in a highly regulated and 
selective manner. PP1-interacting proteins (PIPs) function as targeting subunits, substrates 
and/or inhibitors (Bollen et al., 2001; 2010). PIPs form stable complexes with PP1 via 
degenerate docking motifs, often in the context of structurally disordered interaction 
domains. PP1 is regulated by more than 100 known PIPs that distinctly and specifically 
regulate PP1 to enable rapid responses to cellular alterations (Fardilha et al., 2010). I-2 
belongs to a class of IUPs and has a number of domains that are involved in the interaction 
of PP1, and interestingly, does not require phosphorylation to inhibit PP1, forming a PP1-I-
2 complex that reveals three crucial interaction sites, involving an RVxF-motif, a SILK-
sequence and a long α-helix, that covers the active site, preventing PP1 activity. Thus, this 
binding does not induce conformational changes to PP1, but trigger the release of one or 
two catalytic metal ions (Bollen et al., 2010; Dancheck et al., 2008; Hurley et al., 2007).  
The importance of PP1-I-2 complex in the regulation of sperm motility has been well 
documented in the literature (Fardilha et al., 2004; Hung and Vijayaraghavan, 2004; 
Vijayaraghavan et al., 1996; 2000). Sperm cells are terminally differentiated cells that 
essentially devoid transcriptional and translational activity. Thus, PP1 driven endogenous 
regulation of protein phosphorylation and sperm motility could represent an important 
mechanism for the physiological regulation of a cell that encounters dramatically different 
environments as its journeys through the seminiferous tubules and the female reproductive 
tract.  
In order to find which PP1 partners might be involved in the control of sperm 
motility, we embarked on a study aimed at defining the testis specific interactomes of 
PP1γ1 and PP1γ2, the two known alternatively splicing variants of the PP1γ gene (Fardilha 
et al., 2004). To accomplish this aim, exhaustive screens were performed using a human 
testis cDNA library. Here, we report the discovery of a new PP1 binding protein, termed I-
2L, that is 95% identical to I-2 at the amino acid level. I-2L retains the I-2 most important 
sequences observed for the interaction with PP1 as showed by bioinformatics analysis 
(Chapter 2), such as the SILK-motif (
12
KGILK
16
), important for the inhibitory capacity of 
I-2, and the degenerated RVxF-motif (
43
KSQKW
47
) that binds to the hydrophobic groove 
behind the PP1 catalytic site. Furthermore, I-2L also contains the putative nuclear 
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 67 
 
localization signal (
136
KKRQFEMKR
144
) indicating that I-2L, can differentially localize to 
the cytoplasm or nucleus, depending on the phase of the cell cycle (Leach et al., 2002).
 
The major difference between I-2 and I-2L is the substitution of the main PP1 
regulatory residue Thr73 for Pro73 in I-2L sequence. The absence of GSK-3 
phosphorylation site at Thr73 in I-2L raises an interesting question: is there an alternative 
mechanism for the inhibitory control of PP1 holoenzyme by the I-2L that rule out the 
phosphorylation by GSK-3? Certainly, several studies demonstrated that PP1γ2 and GSK-3 
activities are two- and six- fold higher, respectively, in immature caput compared to motile 
epididymal sperm. This raises another question: is the inhibition by I-2L more effective in 
the epididymal cauda that could explain the unidirectional acquisition of sperm motility 
along the epididymal tract? Indeed, variation in only nine amino-acids (5%) introduces 
differences in the signal transduction regulation of these almost identical proteins. This 
could confer completely different functions to the PP1c-I-2 and PP1c-I-2L complexes, 
specifically in what concerns to sperm motility (Figure 9). Considering the above data, it 
seems reasonable to hypothesize a possible role for I-2L functions in sperm. Being 
associated with PP1γ2 in sperm tail, it might be involved in the control of sperm motility. 
Our theoretical model (Figure 25) indicates that, along the epididymis, I-2 concentration 
decreases and I-2L increases, leading to a reduction in PP1 activity from the caput to the 
caudal portion of the epididymis. This would be an extremely good explanation to the 
unidirectional acquisition of sperm motility.  
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Figure 25: Model of a putative regulation mechanism of the PP1c-I-2L complex and sperm motility. I-2L 
expression increases along the epididymis, and by contrary, I-2 expression decreases. This could lead to the 
formation of a PP1c-I-2L constitutive inactive complex in caudal motile sperm that could not be reactivated 
by phosphorylation of Thr73 residue by GSK-3 kinase, once it is absent in I-2L.  
 
The presence of I-2/I-2L in human sperm was confirmed by immunoblot and 
immunocytochemistry analysis, using a specific anti-I-2 antibody which recognizes both 
proteins. Our results demonstrated that I-2/I-2L is highly expressed in human sperm 
together with PP1γ2. Additionally, the results indicated that I-2/I-2L co-localize 
endogenously with the PP1γ2 isoform in the principal-piece and middle-piece of 
spermatozoa flagellum, consistent with the role of PP1-(I-2/I-2L) in the sperm motility. 
Our results also demonstrated that I-2/I-2L co-localizes with PP1γ2 in the 
postacrosomal and equatorial segment of the spermatozoa head indicated that I-2L might 
be present in cytoplasm being essential for the acrosome reaction. The presence of a 
putative PKC phosphorylation site indicates that I-2L may be an intermediate between 
calcium signaling and PP1γ2 regulation of sperm acrosome reaction (Figure 26).  
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Figure 26: Schematic representation of the co-localization of I-2L with PP1γ2 in the postacrosomal and 
equatorial segment of the spermatozoa head.  The presence of I-2L in the cytoplasm of the postacrosomal and 
equatorial segment may be essential for the spermatozoa acrosome reaction. The phosphorylation of I-2L by 
PKC may activate the PP1γ2 that may act in the opening of the calcium channels in the plasmatic membrane, 
promoting the release of calcium to the cytosol. 
 
Sperm undergo acrosome reaction when they bind to the egg´s zona pellucida, 
enabling the sperm to penetrate the egg. Prior to this binding, the spermatozoa undergo in 
the female reproductive tract a series of biochemical transformations, involving the 
elevation of cytosolic calcium and a signal transduction cascade that culminate in the 
activation of cAMP/PKA and PKC that leads to the sperm acrosome reaction. PKA and 
IP3 activate the calcium channels in the outer acrosome membrane, resulting in membrane 
fusion and acrosome reaction. PKC opens the calcium channel in the plasma membrane 
increasing the concentration of cytosolic calcium that promotes the fusion between the 
plasma membrane and the outer acrosome membrane (Breitbart, 2002; Turner, 2003). 
Through bioinformatics analysis we concluded that I-2//I-2L have three putative 
phosphorylation sites for PKC at the Ser7, Ser41 and Ser44 residues, indicating that I-2L 
may be involved in the acrosome reaction, as suggested by our immunocytochemical 
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results. Our hypothesis is that the phosphorylation of I-2L by PKC may activate the PP1γ2 
that may regulate the opening of the calcium channels in the plasmatic membrane, 
promoting the release of calcium to the cytosol (Figure 26).  
We proposed that I-2L is an expressed gene producing a functional protein that 
interacts with the testis- and sperm- specific PP1γ2 isoform, since it was identified from a 
human testis cDNA library using PP1γ isoforms as baits. However, the similarities 
between I-2 and I-2L in terms of nucleotides and amino acids are enormous, which makes 
it difficult to distinguish them. Our immunoblot and immunocytochemistry results did not 
allow us to reach any conclusions regarding the expression of I-2L protein alone. 
Therefore, with the proposal of confirming that I-2L is expressed and is a PP1γ2-
interacting protein in human sperm, and also to addressing the physiological relevance of 
PP1γ2-I-2L in vivo, we immunoprecipitated I-2/I-2L from human sperm to further analyze 
the peptide fingerprint by mass spectrometry (MS). Through bioinformatics analysis, we 
concluded that the digestion with trypsin originates different patterns of cleavage in the 
amino acid I-2 and I-2L sequences, allowing the distinction between I-2 and I-2L as two 
different proteins expressed by two paralogue genes. Interestingly, the identification of I-
2L by mass spectrometry opens new perspectives for the study of the physiological role of 
the PP1γ2-I-2L complex in the acquisition of sperm motility, where protein 
phosphorylation may constitute a pivotal regulatory mechanism. It will be interesting to 
evaluate the occurrence of I-2L in caput and caudal sperm assessing the formation of 
PP1γ2-I-2L constitutive inactive complex in caudal motile sperm (Figure 25). 
Another relevant way to access the relevance of I-2 and I-2L would be to attempt the 
in vivo overexpression of I-2 and I-2L mice with PGK2 promotor that is directed in a 
strictly tissue-manner in meiotic spermatocytes and postmeioic spermatides during 
spermatogenesis in eutherian mammals (Zhang et al., 1999). Indeed, I-2 or I-2L would be 
expressed only in testis and consequences of their expression would be evaluated on 
spermatogenesis and spermiogenesis. Thus, the hypothesis of the relationship between I-2L 
and the inactivation of PP1γ2 activity in caudal sperm seems worthwhile exploring in the 
future.  
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SDS-PAGE and Immunoblotting Solutions  
 
LGB (Lower Gel Buffer) 
 
To 900 ml of deionized H2O add:  
Tris 181.65 g 
SDS  4 g  
Mix until the solutes have dissolved. Adjust the pH to 8.9 and adjust the volume to 
1L with deionized H2O. 
 
UGB (Upper Gel Buffer) 
  
To 900 ml of deionized H2O add:  
Tris 75.69 g 
Mix until the solute has dissolved. Adjust the pH to 6.8 and adjust the volume to 1L 
with deionized H2O. 
 
30% Acrylamide/0.8% Bisacrylamide 
 
To 70 ml of deionized H2O add: 
Acrylamide 29.2 g 
Bisacrylamide 0.8 g 
Mix until the solutes have dissolved. Adjust the volume to 100 mL with deionized 
H2O. Filter through a 0.2 μm filter and store at 4 °C. 
 
10% APS (ammonium persulfate) 
 
In 10 ml of deionized H2O dissolve 1 g of APS.  
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10% SDS (sodium dodecilsulfate) 
 
In 10 ml of deionized H2O dissolve 1 g of SDS. 
 
(4x) Loading Gel Buffer  
 
1 M Tris solution (pH 6.8) 2.5 ml (250 mM) 
SDS    0.8 g (0.8%) 
Glycerol   4 ml (40%) 
β-Mercaptoethanol  2 ml (2%) 
Bromophenol blue  1 mg (0.01 %) 
Adjust the volume to 10 ml with deionized H2O. Store in darkness at RT. 
 
1 M Tris (pH 6.8) solution 
 
To 150 ml of deionized H2O add: 
Tris base 30.3 g 
Adjust the pH to 6.8 and adjust the final volume to 250 ml. 
 
10x Running Buffer  
 
Tris  30.3 g (250 mM) 
Glycine 144.2 g (2.5 M) 
SDS  10 g (1%) 
Dissolve in deionized H2O, adjust the pH to 8.3 and adjust the volume to 1 L. 
 
10x Transfer buffer  
 
Tris  3.03 g (25 mM) 
Glycine 14.41 g (192 mM) 
Mix until solutes dissolution. Adjust the pH to 8.3 with HCl and adjust the volume 
to 800 ml with deionized H2O. Just prior to use add 200 ml of methanol (20%). 
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10x TBS (Tris buffered saline)  
 
Tris 12.11 g (10 mM) 
NaCl 87.66 g (150 mM) 
Adjust the pH to 8.0 with HCl and adjust the volume to 1 L with deionized H2O.  
 
10x TBST (TBS + Tween)  
 
Tris  12.11 g (10 mM) 
NaCl  87.66 g (150 mM) 
Tween 20 5 ml (0.05%) 
Adjust the pH to 8.0 with HCl and adjust the volume to 1 L with deionized H2O.  
 
Coomassie blue staining solutions 
 
Fixation solution 
 
 Methanol  400 ml 
 Acetic acid 100 ml 
Adjust the volume to 1 L with deionized H2O. 
 
Staining solution 
 
Coomassie Blue G250 1.2 g 
Methanol   200 ml 
Adjust the volume to 1 L with deionized H2O. 
 
Distaining solution 
 
Methanol 250 ml 
Adjust the volume to 1 L with deionized H2O. 
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Immunocytochemistry solutions 
 
1x PBS 
 
For a final volume of 500 ml, dissolve one pack of BupH Modified Dulbecco´s 
Phosphate Buffered Saline Pack (Pearce) in deionized H2O. Final composition, 
 
8 mM Sodium Phosphate 
2 mM Potassium Phosphate 
 40 mM NaCl 
 10 mM KCl 
 Sterilize by filtering through a 0.2 µm filter and store at 4 ºC.  
 
10x 1 mg/ml Poly-L-ornithine solution  
 
To a final volume of 100 ml, dissolved in ionised H2O 100 mg of poly-L-ornithine.  
 
4% Paraformaldehyde 
 
For a final volume of 100 ml, add 4 g of paraformaldehyde to 25 ml of deionized 
H2O. Dissolve by heating the mixture at 58 ºC while stirring. Add 1-2 drops of 1 M 
NaOH to clarify the solution and filter (0.2 µm filter). Add 50 ml of 2x PBS and 
adjust the volume to 100 ml with deionized H2O.  
 
Immunoprecipitation solutions 
 
1x PBS 3% BSA Buffer 
 
For a final volume of 10 ml, add 0.3 g of BSA to 10 ml of 1x PBS and dissolve.  
 
 
 Inhibitor-2L, a novel putative protein phosphatase-1 inhibitor in human sperm  
 
Mestrado em Biologia Molecular e Celular 86 
 
 
1x PBS 3% BSA Buffer + Protease inhibitors 
 
Add to 4 ml of 1x PBS 3% BSA buffer the following quantities for a final volume 
of 5 ml: 
Pepstatin A (1 mg/ml stock solution in DMSO) 23.8 µl  
Leupeptin (5 mg/ml stock solution)   0.72 µl 
Benzamidine (200 mM stock solution)  180 µl 
Aprotinin (2.1 mg/ml stock solution) 43.2 l 
PMSF (10 mM stock solution)   176 µl 
 
Spermatozoa purification solution  
 
NCB stock solutions 
 
10x CaCl2 
 
For a final volume of 10 ml, add 0.027 g of CaCl2 to deionized H2O. Dissolve and 
filter (0.2 µm filter) the solution. 
 
10x KCl 
 
For a final volume of 10 ml, add 0.04 g of KCl to deionized H2O.  
 
10x MgSO4.7H2O 
 
 For a final volume of 10 ml, add 0.02 g of MgSO4.7H2O to deionized H2O. 
 
10x NaCl 
 
For a final volume of 10 ml, add 0.680 g of NaCl to deionized H2O.  
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10x NaHPO4 
 
For a final volume of 10 ml, add 0.016 g of NaHPO4 to deionized H2O.  
 
10x D(+)-Glucose 
 
 For a final volume of 10 ml, add 0.1 g of D(+) glucose to deionized H2O 
 
10x Na piruvate 
 
 For a final volume of 10 ml, add 0.03 g of Na piruvate to deionized H2O. 
 
10x Na lactate 
 
 For a final volume of 10 ml, add 0.468 g of Na lactate to deionized H2O.  
 
10x Hepes 
 
 For a final volume of 10 ml, add 0.0595 g of Hepes to deionized H2O.  
